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Abstract and Keywords 
 
 Cyclopropane 1,1-diesters have been investigated as a source of donor-acceptor 
cyclopropanes, providing an understanding of the mechanism of reaction between these 
cyclopropanes and nitrosoarenes, as well as azo dicarboxylates. Cross-over experiments have been 
utilized to provide key pieces of experimental evidence that help generate a theoretical model of 
the reactions. By understanding these reactions with precision, the avenue to expand the reaction 
scope and develop other useful reactions is opened up. This allows the chemistry to be better 
utilized, providing easier access to important molecules when needed, and contributes to 
advancing the field of synthetic organic chemistry.  
 In addition, cyclobutane 1,1-diesters were also investigated as a source of donor-acceptor 
cyclobutanes. Specifically, their use in cycloaddition reactions has been developed to include the 
reaction of cyclobutanes with cis-diazenes, providing access to hexahydropyridazines. These 
compounds are synthesized in an efficient manner and are known to contain biologically active 
properties. 
 
 
Keywords: donor-acceptor cyclopropane, donor-acceptor cyclobutane, cyclopropane, 
cyclobutane, tetrahydro-1,2-oxazine 
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Chapter 1 - General Introduction 
 
 The use of cyclopropanes and cyclobutanes in synthetic organic chemistry has received a 
considerable amount of attention over the years, with multiple applications being continually 
developed. This chapter serves as an introduction to the chemistry of donor-acceptor (DA) 
cyclopropanes and cyclobutanes, and their utilization in the synthesis of heterocyclic ring systems. 
The focus of the reactions is on the use of 1,1-cyclopropanediesters as a source of DA 
cyclopropanes. The work presented in this thesis was done entirely by me, and the information 
acquired will be published in peer-reviewed journals in the near future. 
 Chapter two investigated the reaction of DA cyclopropanes with nitrosoarenes with the use 
of a cross-over experiment to acquire key experimental data that were used to validate a potential 
reaction mechanism. The chemistry of DA cyclopropanes with nitrones is well known, but similar 
products were produced when the nitrone was switched with a nitroso functional group, so a 
complete mechanism would be valuable for not only understanding this reaction, but in the 
development of new reactions to come when utilizing DA cyclopropanes. 
 Chapter three investigated the reaction of DA cyclopropanes with both cis and trans azo 
dicarboxylates. The chemistry behind the unusual ring opening reaction of DA cyclopropanes with 
specifically cis-diazenes was a key component of this chapter. The use of cross-over experiments 
was used to gain a deeper understanding into these reactions and resulted in a new pattern of 
reactivity which showed similarities to the chemistry presented in chapter two as well. 
 Chapter four investigated the use of DA cyclobutanes in a new cycloaddition reaction with 
cis azo dicarboxylates. It was shown that DA cyclobutanes are able to react with cis-diazenes and 
form hexahydropyridazines ring systems which are a rare type of heterocycle, which have only a 
limited number of synthetic procedures available. 
 The chemistry learned throughout these chapters has shown new procedures to construct 
heterocyclic compounds from DA cyclopropanes and cyclobutanes, and answer mechanistically 
related questions into how these compounds form. These experimental observations have shown 
repeating patterns of reactivity that potentially could be adjusted to include the incorporation of 
new elements, and hopefully help in the discovery or design of new reactions. 
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1.1 Introduction 
 
Cyclopropanes and cyclobutanes have been shown to play an important and useful role in 
synthetic organic chemistry with an array of various reaction partners.1 Comparison of the 
properties of carbocycles show cyclopropane and cyclobutane to have a higher ring strain energy 
due to the distortion of the bond angles away from the ideal 109° angle of the tetrahedron. Figure 
1.1 describes the higher ring strain energy of cyclic compounds when the carbon-carbon bond 
angles in cyclopropane (1) and cyclobutane (2) are not able to adopt an ideal conformation such 
as the lower energy chair form of cyclohexane (4).2 When smaller carbocycles are prepared, their 
inherent ring strain functions as a built-in energy source which can be used as a driving force to 
produce compounds with various uses in chemical synthesis. The unique properties of 
cyclopropanes allow for a very useful activation of sp3 C-C bonds within the cycle, which has 
contributed to an array of different reaction types. These properties are also useful in biological 
settings with many cyclopropane ring-opening reactions occurring in nature. 
 
 
Figure 1.1 Strain energies of small carbocycles 
 
Cyclopropanes are found in natural products and biological settings, including lipids, 
pheromones, terpenes, and steroids.3 Examples include the anti-HIV drug Nevirapine (5), and the 
potent antibiotics Ciprofloxacin (6) and Vigamox (7) as seen in Figure 1.2. Vigamox was ranked 
in the top 200 brand-name drugs by U.S. retail dollars in 2010 with a profit that year of $0.25 
billion.4 
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Figure 1.2 Examples of biologically active compounds containing a cyclopropane ring 
 
Cyclopropanes have had many uses in synthetic chemistry, such as in total synthesis, and 
in the preparation of many useful compounds. In order to make use of the cyclopropane ring and 
control which bonds will break to undergo reaction, activating groups are strategically used. The 
cyclopropane ring is reactive due to its high ring strain, but activating groups are commonly present 
on the ring to selectively increase, and control reactivity. The effects of activating groups can also 
be enhanced or activated using thermal or catalytic conditions. 
 
1.1.1 Donor-Acceptor (DA) Cyclopropanes 
 
Increased reactivity can be achieved when donor and acceptor groups are arranged in a 
vicinal relationship on the carbocycle to activate the bond between the two groups and allow for 
different reaction types.5 Common examples of electron donating groups (EDG) include: alkoxy, 
amino, aryl, vinyl, and other groups that can stabilize carbocations. Examples of electron 
withdrawing groups (EWG) commonly include: esters, carbonyls, and other groups that can 
stabilize carbanions.6 
Activation of donor-acceptor (DA) cyclopropanes (8) and cyclobutanes with Lewis acids 
allow formation of 1,3-dipole (9) and 1,4-dipole intermediates, respectively. Scheme 1.1 shows 
how DA cyclopropanes are able to react with various electrophiles, nucleophiles, or dipolarophiles. 
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Scheme 1.1 General reactions of DA cyclopropanes 
 
DA cyclopropanes have been extensively studied over the last 50 years and serve as a 
synthetically useful 1,3 carbon dipolarophile. This allows for multiple applications such as serving 
as starting materials for the synthesis of highly substituted 5- and 6-membered carbocycles and 
heterocycles via annulation (cycloaddition) reactions. 
 
1.1.2 Cycloadditions of DA Cyclopropanes 
 
Cycloaddition chemistry has the ability to produce a wide range of molecular architecture 
often with high levels of control and efficiency.7 Cycloadditions have also proven to be an effective 
method for the construction of heterocyclic compounds. The ability to efficiently access different 
heterocyclic motifs has great importance because of the interesting biological activities that are 
often associated with the systems when found in living organisms. Active heterocycles have shown 
considerable biological actions, such as antifungal, anti-inflammatory, antibacterial, 
anticonvulsant, antiallergic, herbicidal, anticancer activity.8 A main focus of this thesis is on 
cycloadditions of DA cyclopropanes with different dipolarophiles, and understanding their 
mechanism of action in the creation of heterocyclic compounds. 
Cycloadditions belong to a broader class of reactions known as pericyclic reactions. 
Pericyclic reactions are often characterized by a simultaneous event of bond breaking and bond 
creating in the reaction process. This attribute often provides a way of controlling the 
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stereochemistry for a specific reaction. In some cases, the stereochemistry of the starting material 
can control the stereochemical outcome of the product. This type of prediction is made more 
accurately when a complete understanding of the reaction mechanism and transition states are 
known. 
Typical cycloadditions often occur through tightly held or compact transition states which 
is governed my maximum orbital overlap between reaction partners.9 These so-called “closed” 
transition states are powerful tools in the asymmetric synthesis field for analyzing enantio-
selective and diastereo-selective reactions. Acquiring accurate models of transition states is 
therefore of upmost importance in the understanding of stereo-selective reactions. In addition to 
understanding transition states, it may also be of equal importance to understand the overall 
mechanism of a reaction. 
DA cyclopropanes, such as 1,1-cyclopropane diesters react in a similar way to alkenes 
substituted with an electron withdrawing group (EWG), such as α,β-unsaturated carbonyl 
systems.10 The difference is the additional carbon in the cyclopropane ring, which makes the 
reaction a one carbon homologation as seen in the [3+2], and homo [3+2] cycloaddition (Scheme 
1.2). 
 
 
Scheme 1.2 Cycloaddition of nitrones with α,β-unsaturated systems and cyclopropanes 
 
1.1.3 Cycloadditions of DA Cyclopropanes with Nitrones 
 
Nitrones (13) have been shown to react with 1,1-cyclopropane diesters (18) in the presence 
of Yb(OTf)3 to yield tetrahydro-1,2-oxazines (19) with a high degree of regio- and stereo-control, 
as seen in scheme 1.3.11 
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Scheme 1.3 Homo [3+2] cycloaddition of nitrones with DA cyclopropanes 
 
Single-crystal X-Ray analysis has shown that the observed product always forms a single 
diastereomer in which the substituents at the C3 and C6 position are always in a cis relationship. 
This type of transformation is an example of a dipolar homo [3+2] cycloaddition, but is also 
considered a 1,3-dipolar cycloaddition, and was first reported by the Kerr group in 2003. 
Mechanistic studies have been carried out with quantum chemical DFT calculations and indicate 
that two very similar, but distinct, reaction pathways may account for the transformation, and can 
be seen in Scheme 1.4.12 One pathway is an asynchronous concerted mechanism that involves an 
approximate half-chair-like transition state where the oxygen of the nitrone leads the attack on the 
cyclopropane ring (I). The second pathway is a stepwise mechanism which involves a zwitterionic 
imminium intermediate, with the oxygen of the nitrone again leading the attack on the 
cyclopropane ring (II). Understanding this transformation in detail has helped discover another 
transformation, where DA cyclopropanes are capable of reacting with nitrosoarenes. 
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Scheme 1.4 Mechanism of cycloaddition of DA cyclopropanes with nitrones 
 
In 2004 the Kerr group showed that this reaction could be carried out using a three-
component coupling strategy between an aldehyde (21) and a hydroxylamine (20) as seen in 
Scheme 1.5. In this strategy, the nitrone (13) is formed in situ, which is useful when dealing with 
nitrones that are difficult to prepare or are unstable due to oligomerization under the required Lewis 
acidic conditions.13 
 
 
Scheme 1.5 Three-component homo [3+2] cycloaddition 
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In order to address the issue as to whether this reaction mechanism is going through a 
concerted or step-wise pathway, extensive studies were performed using enantio-pure starting 
materials. Therefore the reaction of enantiomerically enriched 3-methyl-2-phenylcyclopropane-
1,1-dicarboxylates with nitrones was performed by Dr. Michael Kerr in 200714, as shown in 
scheme 1.6. 
 
 
 
Scheme 1.6 Mechanism studies on cycloadditions of DA cyclopropanes with nitrones 
 
A key piece of information discovered in this study is the inversion of stereochemistry at 
C2 for both cis and trans diastereomers of the starting material. The results provided experimental 
evidence that supports the idea of a step-wise pathway and not a concerted pathway. In the step-
wise pathway, there is an inversion of stereochemistry when the oxygen from the nitrone acts as a 
nucleophile and opens the cyclopropane ring. 
Experimental evidence that also helps support the mechanism proposed by Dr. Michael 
Kerr was provided when optically active cyclopropanes were reacted with nitrones in the presence 
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of a catalytic amount of Ni(ClO4)2 without a chiral ligand to give the tetrahydro-1,2-oxazine in a 
high yield with the same level of enantiomeric purity as that of the starting material.15 
 This work by Tang et al shows how understanding the proposed mechanism of a reaction 
can lead to other discoveries, in this case, applications for kinetic resolution was developed. This 
was made possible because of the diligent mechanistic studies performed by Dr. Michael Kerr to 
understand the reaction with a high level of understanding. 
 
1.1.4 Tetrahydro-1,2-Oxazines 
 
The tetrahydro-1,2-oxazine motif is rarely found in nature, appearing in only a small 
number of natural products. Examples of these natural products include FR900482 (27) and 
FR66979 (28) as seen in Figure 1.3, which exhibit antitumor and antibiotic properties.16 Both of 
these natural products are structurally similar to the mitomycins, including mitomycin C, which 
has been in widespread clinical use for more than 20 years. The biological activities of FR900482 
and FR66979 are also similar to the mitomycins, which are both reductively activated in vivo and 
covalently cross-link DNA in a fashion analogous to the mitomycins. The difference in structures 
that ultimately causes a different mechanism of bio-reductive activation between the mitomycins 
and FR900482, cause FR900482 to not exhibit oxidative strand scission of DNA and to not 
produce a superoxide radical anion during activation. The FR900482 class of compounds 
represents a compelling clinical replacement for mitomycin C, given its greatly reduced host 
toxicity and superior DNA interstrand cross-linking efficacy. 
 
 
Figure 1.3 Tetrahydro-1,2-oxazine motif in natural and synthetic compounds 
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FK317 (29) and FK973 (30) are synthetic analogs of the natural products FR900482 and 
FR66979, and also contain the tetrahydro-1,2-oxazine system. The antitumor activity of FK317 
was found to be equivalent to, or stronger than cisplatin, mitomycin C, and Taxol. Because of 
compounds such as FR900482 and FR66979 which contain the tetrahydro-1,2-oxazine system and 
show interesting biological features, new synthetic routes to the tetrahydro-1,2-oxazine core are 
useful because of the limited ways in which these systems can be created. These limitations have 
made the tetrahydro-1,2-oxazine ring difficult to synthesize in the past, so having the ability to 
form the system in a controlled manner is definitely beneficial to the synthetic community. This 
project looks at how cycloaddition chemistry can be utilized as an effective method for 
heterocyclic ring construction, and how understanding the process mechanistically may lead to the 
discovery of other reaction types. It is already know that DA cyclopropanes react with nitrones to 
form the tetrahydro-1,2-oxazine ring, and a goal of this project is to discover other partners that 
are compatible with DA cyclopropanes to form these systems as well as other interesting 
heterocycles. 
The post modification of tetrahydro-1,2-oxazines has been examined by Dr. Michael Kerr 
and has led to some interesting and important uses for the ring system. Selective N-O cleavage of 
the tetrahydro-1,2-oxazine ring has been utilized in the synthesis of amino alcohols. The amino 
alcohols have then been used to construct pyrrolidines which has applications in the total synthesis 
of Nakadomarin A for example.17 Pyrrole synthesis has also emerged as a tool made possible from 
post modification of the ring system.18 These useful applications showcase how important these 
molecules are, and how important it is to obtain these compounds in an efficient and controllable 
manner. 
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Chapter 2 - Cycloadditions of Donor-Acceptor Cyclopropanes with Nitrosoarenes 
 
2.1 Introduction 
 
 Nitrosoarenes have been coupled with DA cyclopropanes in the synthesis of various 
heterocyclic ring systems.19 Although reactions of nitrosoarenes and DA cyclopropanes have been 
reported, their potential has still yet to be reached. The discovery of new reactions utilizing the 
nitroso functional group is still ongoing and demonstrates the versatility in the construction of 
heterocyclic systems. The nitrogen-oxygen single bond that forms when nitrosoarenes are used in 
ring construction, has been shown to be a site of functionalization for the production of important 
molecules such as amino alcohols.20 
 
2.1.1 Cycloadditions of DA Cyclopropanes with Nitrosoarenes 
 
Previous research in the Studer group21 has shown DA cyclopropanes to be a compatible 
reaction partner with nitrosoarenes, which undergo a [3+2] cycloaddition forming isoxazolidines 
when catalyzed with MgBr2 as seen in scheme 2.1. The successful use of DA cyclopropanes with 
nitrosoarenes in cycloaddition reactions encouraged the Pagenkopf group to determine if these 
reaction partners were able to undergo other transformations. 
 
 
 
Scheme 2.1 [3+2] Cycloaddition of DA cyclopropanes with nitrosoarenes 
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Figure 2.1 Catalytic cycle of [3+2] cycloaddition of DA cyclopropanes with nitrosoarenes 
 
The mechanism (Figure 2.1) shows a bromide ion attacking and opening the cyclopropane 
ring, which drew my attention because of the Pagenkopf group’s interest in Yb(OTf)3 catalyzed 
DA cyclopropane cycloaddition chemistry. Under Yb(OTf)3 catalytic conditions, only the triflate 
ion would be present as a counter-ion and would presumably be less nucleophilic towards the 
cyclopropane, allowing the nitrosoarene a chance to act as the nucleophile and perhaps open the 
cyclopropane ring in a [3+2] annulation to yield an isooxazolidinine. The initial hope was in 
opening of the DA cyclopropane in a manner that would yield the opposite regio-isomer as the 
Studer group. Instead of observing an isooxazolidinine, a tetrahydro-1,2-oxazine motif was 
formed. 
 
2.2 Results and Discussion 
 
Interestingly, it was discovered that when nitrosoarenes were allowed to react with DA 
cyclopropanes, the tetrahydro-1,2-oxazine motif was formed when catalyzed with Yb(OTf)3 under 
refluxing conditions. The observed cis stereochemical outcome of the tetrahydro-1,2-oxazine ring 
13 
 
 
 
is consistent with Kerr’s reaction of DA cyclopropanes with nitrones. A nitrone intermediate may 
account for the formation of the tetrahydro-1,2-oxazine system. This assumption was backed up 
by experimental evidence when considering the yield of the reaction. When both starting materials 
were used in a 1:1 ratio of equivalents, a yield of 44% was observed (Scheme 2.2). When using a 
2:1 ratio of cyclopropane to nitrosoarene, a yield of 87% was observed. This observation shows 
how two equivalents of the cyclopropane may be combining to form a nitrone in situ, which then 
reacts with the nitrosoarene. Understanding the mechanics of this unprecedented reaction may lead 
to the discovery of other reaction types and reaction partners for DA cyclopropanes. 
 
 
 
Scheme 2.2 Reaction of DA cyclopropane with nitrosoarene 
 
The physical properties of the tetrahydro-1,2-oxazine produced by this method are an exact 
match to the tetrahydro-1,2-oxazine produced from Kerr’s methodology. The 1H NMR of 
compound 35a prepared from DA cyclopropane 34a and nitrosobenzene 32a is shown in Figure 
2.2. 
 
 
 
Figure 2.2 1H NMR of tetrahydro-1,2-oxazine 35a 
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The NMR of the product from scheme 2.2 was compared to the identical compound 
synthesized using Kerr’s three-component coupling strategy and is shown in Scheme 2.3 and 
Figure 2.3. 
 
 
Scheme 2.3 Three component synthesis of tetrahydro-1,2-oxazine 
 
 
 
Figure 2.3 1H NMR of tetrahydro-1,2-oxazine 35a prepared from Kerr’s method 
 
 The matching NMR data provided experimental evidence that both methods lead to the 
same compound and, therefore, access to tetrahydro-1,2-oxazine is possible when reacting 1,1-
cyclopropane diesters with nitrosoarene compounds. 
To find reaction conditions that produce the highest yields and come to a better 
understanding of this reaction, an optimization experiment was carried out (Table 2.1). The 
reaction of DA cyclopropanes with nitrosoarenes was performed under different conditions until 
the production of tetrahydro-1,2-oxaizine was achieved in an efficient and reproducible manner. 
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Table 2.1 Optimization of Yb(OTf)3 catalyzed reaction of DA cyclopropanes with nitrosoarene 
 
 
Entrya Cyclopropane 
(Equivalents) 
Nitrosoarene 
(Equivalents) 
Time 
(Hours) 
Yb(OTf)3 
(mol %) 
Yield 
(%)b 
1 1 2 20 10 42 
2 1 1 20 10 44 
3 2 1 18 10 87 
4 4 1 16 10 76 
5 2 1 15 5 72 
6 2 1 9 20 80 
a Typical reaction conditions: Cyclopropane and nitrosoarene were added to a solution of 
Yb(OTf)3 in 1,2-DCE (3 mL) at room temperature. Reactions were monitored by thin layer 
chromatography (TLC) until cyclopropane was consumed. b Isolated yield. 
 
 
 A cross-over experiment, which is a method used to study the mechanism of a chemical 
reaction, was used to address this reaction and the experimental evidence gained would help 
develop a rational reaction mechanism. A mechanism that would account for this overall 
transformation is shown in Scheme 2.4, and demonstrates how the nitrosoarene starts by attacking 
the first equivalent of cyclopropane, then forming a nitrone in situ. The nitrone would then react 
with the second equivalent of cyclopropane, in a known homo [3+2] cycloaddition, shown in a 
step-wise sequence. 
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Scheme 2.4 Proposed mechanism for the reaction of DA cyclopropanes with nitrosoarenes 
 
To investigate the proposed reaction mechanism, a cross-over experiment was designed to 
provide key mechanistic details. The theoretical mechanism can be analyzed by using two different 
cyclopropanes as the starting materials in a cross-over experiment with nitrosobenzene. 
 
2.2.1 Synthesis of DA cyclopropanes 
 
Cyclopropanes were prepared using a two-step procedure utilizing a Knoevenagel 
condensation followed by a Corey-Chaykovsky reaction (Table 2.2). Two different cyclopropanes 
were required for the cross-over experiment and additional cyclopropanes were also prepared to 
explore the reaction scope for compatibility with various nitrosoarenes. 
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Table 2.2 Synthesis of DA cyclopropanes 
 
 
Entrya Cyclopropane Product Yield (% over 2 
steps)b 
1 Ar = C6H5, R = Me 34a 76 
2 Ar = 4-MeC6H4, R = Me 34b 87 
3 Ar = C6H5, R = Et 34c 82 
4 
5 
Ar = 4-MeC6H4, R = Et 
Ar = 2-thienyl, R = Me 
34d 
34e 
83 
70 
 a Typical reaction conditions: L-Proline (1.88 mmol) was added to a solution of aldehyde 
(18.8 mmol) in DMSO (6 mL) followed by dialkyl malonate (37.6 mmol) and stirred for 24 
h at room temperature. NaH (1.7 mmol) was added to trimethylsulfoxonium iodide (1.7 
mmol) in DMF (3 mL) and stirred for 1 h at room temperature before adding the Knoevenagel 
product (1.4 mmol). Reactions were monitored by TLC until cyclopropane was consumed. b 
Isolated yield. 
 
 
2.2.2 Cross-Over Experiment #1 
 
Using starting material that consisted of two different DA cyclopropanes (34a, 34d) would, 
in theory, generate two different nitrone intermediates (38, 43) as seen in Scheme 2.5. Nitrone 
intermediate 38 would react with cyclopropane 34a and cyclopropane 34d giving rise to products 
35a and 35c. The other nitrone intermediate (43) would react again with cyclopropane 34a and 
cyclopropane 34d, giving rise to products 35b and 35d. Identification of all four products in the 
reaction mixture would confirm that a reaction is taking place in which there is cross-over between 
the two different cyclopropanes and the two different nitrone intermediates. 
The four expected products were synthesized individually from a three component 
coupling, homo [3+2] dipolar cycloaddition. Once each tetrahydro-1,2-oxazine product was 
18 
 
 
 
synthesized, they were used as standards and compared against the reaction mixture of the cross-
over experiment. The three component coupling reaction was performed by making a nitrone in 
situ from the respective aldehyde and hydroxylamine as seen in Table 2.3. 
 
Table 2.3 Synthesis of tetrahydro-1,2-oxazine standards 
 
 
Entrya Aldehyde Cyclopropane Product Yield (%)b 
1 Ar1 = C6H5 Ar2 = C6H5, R= Me 35a 64 
2 Ar1 = 4-MeC6H4 Ar2 = C6H5, R= Me 35b 81 
3 Ar1 = C6H5 Ar2 = 4-MeC6H4, R= Et 35c 77 
4 Ar1 = 4-MeC6H4 Ar2 = 4-MeC6H4, R= Et 35d 63 
 a Typical reaction conditions: To a solution of hydroxylamine (0.46 mmol) and 
aldehyde (0.50 mmol) in toluene (2 mL) at room temperature, were added Yb(OTf)3 
and 4Å molecular sieves. Reactions were monitored by TLC. b Isolated yield. 
 
After synthesis and characterization, the standards with their respective Rf values were 
spotted against the reaction mixture of the cross-over experiment and developed in Hexanes:Ethyl 
Acetate (3:1) on a TLC plate. All four standards in the reaction mixture were identified. All four 
tetrahydro-1,2-oxazines (35a - 35d) were isolated from the reaction mixture of cross-over 
experiment #1 to provide isolated yields as seen in Scheme 2.5. All four products in the reaction 
mixture (from cross-over experiment #1) was verified with NMR and GC-MS data, which were 
analyzed by comparison to the individual standards produced from Table 2.3 
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Scheme 2.5 Cross-over experiment for the reaction of DA cyclopropanes with nitrosoarenes 
 
2.2.3 Reaction Scope 
 
After gaining a better understanding and optimizing the reaction of DA cyclopropanes with 
nitrosoarenes, the optimal conditions were applied to other nitrosoarenes to investigate and expand 
the reactions scope, as seen in Table 2.4. 
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Table 2.4 Reaction scope with different nitrosoarenes 
 
 
Entrya Nitrosoarene Product Yield (%)b 
1 Ar = 3-BrC6H4 44a 73 
2 Ar = 4-BrC6H4 44b 75 
3 Ar = 3-CO2EtC6H4 44c 80 
4 Ar = 4-CO2EtC6H4 44d 78 
5 Ar = 3,4-Cl2C6H3 44e 91 
6 Ar = 3-C(O)MeC6H4 44f 68 
7 Ar = N-Boc-5-Indole 44g 55 
 a Typical reaction conditions: To a solution of Yb(OTf)3 in 1,2-DCE (3 mL) at room 
temperature, was added cyclopropane (0.43 mmol) and nitrosoarene (0.22 mmol). Reactions 
were monitored by TLC until cyclopropane was consumed. b Isolated yield. 
 
After expansion of the reaction scope to include different nitrosoarenes, additional DA 
cyclopropanes were explored. Table 2.5 shows different DA cyclopropanes that are compatible 
with the reaction conditions in forming tetrahydro-1,2-oxazines. 
 
 
 
 
 
 
 
 
 
 
21 
 
 
 
Table 2.5 Reaction scope with different DA cyclopropanes 
 
 
Entrya Cyclopropane Product Yield (%)b 
1 Ar = C6H5, R = Me 35a 87 
2 Ar = C6H5, R = Et 35e 62 
3 Ar = 4-MeC6H4, R = Me 35f 46 
4 
5 
Ar = 4-MeC6H4, R = Et 
Ar = 2-thienyl, R = Me 
35d 
35g 
70 
69 
 a Typical reaction conditions: To a solution of Yb(OTf)3 in 1,2-DCE (3 mL) 
at room temperature, was added cyclopropane (0.43 mmol) and nitrosoarene 
(0.22 mmol). Reactions were monitored by TLC until cyclopropane was 
consumed. b Isolated yield. 
 
 A new method of synthesizing tetrahydro-1,2-oxazines from DA cyclopropanes and 
nitrosoarenes under Yb(OTf)3 catalysis has been developed. A mechanism that accounts for this 
overall transformation has been presented and experimental data obtained from a cross-over 
experiment provided supporting evidence. The reaction scope was investigated and it was found 
that the reaction conditions were compatible with different nitrosoarenes and DA cyclopropanes. 
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2.3 Experimental 
 
All reactions were performed in an atmosphere of dry argon unless otherwise noted. Flasks 
were oven-dried at approximately 110 °C overnight and cooled in a desiccator prior to use. 
Solvents and reagents were purified according to standard procedures. Dichloromethane was 
purified by passing the solvent through a column of activated alumina. 1,2-Dichloroethane was 
dried by stirring with CaH2 for one hour prior to distillation. All other chemicals were of reagent 
quality and used as obtained from commercial sources unless otherwise noted. The progress of 
reactions was monitored by TLC performed on F254 silica gel plates. The plates were visualized 
using UV light (254 nm) or by staining with ceric ammonium molybdate (CAM) or KMnO4. 
Column chromatography was performed with Silica Flash P60 60 Å silica gel (purchased from 
Silicycle) using flash column chromatography techniques. 
1H and 13C NMR data were obtained on Mercury 400 or Inova 600 MHz spectrometers and 
chemical shifts were reported in parts per million (ppm). All spectra were obtained in deuterated 
chloroform and referenced to residual chloroform at δ 7.26 ppm for 1H spectra and the center peak 
of the triplet at δ 77.0 ppm for 13C spectra. When peak multiplicities are given, abbreviations are 
as follows: s, singlet; d, doublet; t, triplet; q, quartet; dd, doublet of doublets; dt, doublet of triplets; 
m, multiplet. EI high-resolution mass spectra (HRMS) were recorded on a Finnigan MAT 8200 
mass spectrometer at an ionizing voltage of 70 eV. 
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2.4 Supporting Information 
 
General Three Component Coupling Procedure 
 To a solution of hydroxylamine (0.46 mmol, 1.3 equiv) and aldehyde (0.50 mmol, 1.4 
equiv), in toluene (2 mL) was added 4Å molecular sieves and Yb(OTf)3 (0.04 mmol, 0.1 equiv) 
and stirred for 30 min. Cyclopropane (0.36 mmol, 1.0 equiv) was then added and stirred for 20 h 
at rt, then directly loaded onto a packed SiO2 column. Product was purified by flash 
chromatography (9:1 hexanes/EtOAc) to afford the corresponding cycloadducts. 
 
 
Dimethyl 2,3,6-triphenyl-1,2-oxazinane-4,4-dicarboxylate (35a) 
The general three component coupling procedure was followed using hydroxylamine (50 mg, 0.46 
mmol), aldehyde (0.05 mL, 0.50 mmol), Yb(OTf)3 (22 mg, 0.036 mmol) and cyclopropane 34a 
(84 mg, 0.36 mmol) to yield the compound as a yellow oil. The yellow oil was recrystallized with 
CH2Cl2/Hexane to give a white solid (100 mg, 64%). Rf 0.40 (3:1 Hexanes:EtOAc); 1H NMR (400 
MHz, CDCl3) 7.56 - 7.60 (m, 4 H), 7.47 (app t, J = 7.4 Hz, 2 H), 7.38 - 7.42 (m, 1 H), 7.09 - 7.22 
(m, 7 H), 6.81 (app t, J = 7.0 Hz, 1 H), 5.80 (s, 1 H), 5.03 (dd, J = 12.1, 2.3 Hz, 1 H), 3.93 (s, 3 H), 
3.48 (s, 3 H), 2.86 (dd, J = 14.5, 12.1 Hz, 1 H), 2.78 (dd, J = 14.5, 2.3 Hz, 1 H); 13C NMR (100 
MHz, CDCl3) 170.1, 168.3, 148.5, 139.4, 135.0, 130.4, 128.6, 128.5, 128.3, 128.1, 128.0, 126.5, 
121.6, 115.8, 78.8, 65.7, 59.5, 53.5, 52.6, 31.6; HRMS C26H25NO5 Calculated = 431.1733, Found 
= 431.1736 
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Dimethyl 2,6-diphenyl-3-(p-tolyl)-1,2-oxazinane-4,4-dicarboxylate (35b) 
The general three component coupling procedure was followed using hydroxylamine (60 mg, 0.55 
mmol), aldehyde (0.07 mL, 0.60 mmol), Yb(OTf)3 (27 mg, 0.043 mmol) and cyclopropane 34a 
(100 mg, 0.43 mmol) to yield the compound as a yellow oil. The yellow oil was recrystallized with 
CH2Cl2/Hexane to give a white solid (155 mg, 81%). Rf 0.45 (3:1 Hexanes:EtOAc); 1H NMR (400 
MHz, CDCl3) 7.57 (app d, J = 7.4 Hz, 2 H), 7.45 - 7.49 (m, 4 H), 7.38 - 7.42 (m, 1 H), 7.09 - 7.17 
(m, 4 H), 7.00 (app d, J = 7.8 Hz, 2 H), 6.79 - 6.83 (m, 1 H), 5.78 (s, 1 H), 5.03 (dd, J = 12.1, 2.3 
Hz, 1 H), 3.92 (s, 3 H), 3.51 (s, 3 H), 2.87 (dd, J = 14.5, 12.1 Hz, 1 H), 2.78 (dd, J = 14.5, 2.3 Hz, 
1 H), 2.23 (s, 3 H); 13C NMR (100 MHz, CDCl3) 170.1, 168.3, 148.6, 139.5, 137.6, 131.9, 130.3, 
121.5, 115.7, 78.8, 77.3, 76.7, 65.4, 59.6, 53.5, 52.7, 31.6, 21.1; HRMS C27H27NO5 Calculated = 
445.1889, Found = 445.1882 
 
 Diethyl 2,3-diphenyl-6-(p-tolyl)-1,2-oxazinane-4,4-dicarboxylate (35c) 
The general three component coupling procedure was followed using hydroxylamine (50 mg, 0.46 
mmol), aldehyde (0.05 mL, 0.50 mmol), Yb(OTf)3 (22 mg, 0.036 mmol) and cyclopropane 34d 
(100 mg, 0.36 mmol) to yield the compound as a yellow oil. The yellow oil was recrystallized with 
CH2Cl2/Hexane to give a white solid (132 mg, 77%). Rf 0.55 (3:1 Hexanes:EtOAc); 1H NMR (400 
MHz, CDCl3) 7.57 - 7.59 (m, 2 H), 7.45 (app d, J = 8.2 Hz, 2 H), 7.28 (s, 1 H), 7.08 - 7.17 (m, 7 
H), 6.80 (app t, J = 7.0 Hz, 1 H), 5.78 (s, 1 H), 5.00 (dd, J = 12.1, 2.3 Hz, 1 H), 4.38 (q, J = 7.0 Hz, 
2 H), 3.87 - 3.94 (dddd, J = 7.0, 7.0, 7.0, 10.5 Hz, 2 H), 2.87 (dd, J = 14.5, 12.1 Hz, 1 H), 2.76 (dd, 
J = 14.5, 2.3 Hz, 1 H), 2.41 (s, 3 H), 1.36 (t, J = 7.2 Hz, 3 H), 1.03 (t, J = 7.0 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) 169.6, 168.0, 148.7, 138.1, 136.6, 135.1, 130.6, 129.3, 128.5, 128.0, 127.9, 
126.5, 121.4, 115.8, 78.7, 65.7, 62.3, 61.8, 59.4, 31.7, 21.3, 14.2, 13.7; HRMS C29H31NO5 
Calculated = 473.2202, Found = 473.2195 
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Diethyl 2-phenyl-3,6-di-p-tolyl-1,2-oxazinane-4,4-dicarboxylate (35d) 
The general three component coupling procedure was followed using hydroxylamine (50 mg, 0.46 
mmol), aldehyde (0.05 mL, 0.50 mmol), Yb(OTf)3 (22 mg, 0.036 mmol) and cyclopropane 34d 
(100 mg, 0.36 mmol) to yield the compound as a yellow oil. The yellow oil was recrystallized with 
CH2Cl2/Hexane to give a white solid (190 mg, 63%). Rf 0.58 (3:1 Hexanes:EtOAc); 1H NMR (400 
MHz, CDCl3) 7.44 - 7.47 (app dd, J = 8.2, 6.6 Hz, 4 H), 7.27 (app d, J = 8.2 Hz, 2 H), 7.08 - 7.16 
(m, 4 H), 6.97 (app d, J = 8.2 Hz, 2 H), 6.79 (app tt, J = 7.0, 1.6 Hz, 1 H), 5.75 (s, 1 H), 4.98 (dd, 
J = 14.5, 2.3 Hz, 1 H), 4.38 (q, J = 7.0 Hz, 2 H), 3.85 - 3.99 (dddd, J = 7.0, 7.0, 7.0, 10.5 Hz, 2 H), 
2.86 (dd, J = 14.5, 12.5 Hz, 1 H), 2.74 (dd, J = 14.5, 2.3 Hz, 1 H), 2.41 (s, 3 H), 2.21 (s, 3 H), 1.35 
(t, J = 7.0 Hz, 3 H), 1.06 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 169.7, 168.0, 148.7, 
138.1, 137.5, 136.6, 131.9, 130.5, 129.3, 128.6, 128.5, 126.5, 121.3, 115.7, 78.7, 65.4, 62.2, 61.7, 
59.4, 31.7, 21.2, 21.0, 14.2, 13.7; HRMS C30H33NO5 Calculated = 487.2359, Found = 487.2348 
 
General Lewis Acid Catalyzed Cycloaddition Procedure   
 
To a solution of cyclopropane (0.43 mmol, 2.1 equiv) and nitrosoarene (0.20 mmol, 1.0 
equiv) in DCE (3 mL) was added Yb(OTf)3 (0.02 mmol, 0.1 equiv) and stirred for 15 min. The 
mixture was heated to reflux for 3 h then concentrated after consumption of cyclopropane (as 
indicated by TLC) and directly loaded onto a packed SiO2 column. Product was purified by flash 
chromatography (9:1 hexanes/EtOAc) to afford the corresponding cycloadducts. 
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Dimethyl 2,3,6-triphenyl-1,2-oxazinane-4,4-dicarboxylate (35a) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (100 mg, 
0.43 mmol), nitrosobenzene (21 mg, 0.20 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the 
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (75 
mg, 87%). Rf 0.40 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.56 - 7.60 (m, 4 H), 7.47 
(app t, J = 7.4 Hz, 2 H), 7.38 - 7.42 (m, 1 H), 7.09 - 7.22 (m, 7 H), 6.81 (app t, J = 7.0 Hz, 1 H), 
5.80 (s, 1 H), 5.03 (dd, J = 12.1, 2.3 Hz, 1 H), 3.93 (s, 3 H), 3.48 (s, 3 H), 2.86 (dd, J = 14.5, 12.1 
Hz, 1 H), 2.78 (dd, J = 14.5, 2.3 Hz, 1 H); 13C NMR (100 MHz, CDCl3) 170.1, 168.3, 148.5, 139.4, 
135.0, 130.4, 128.6, 128.5, 128.3, 128.1, 128.0, 126.5, 121.6, 115.8, 78.8, 65.7, 59.5, 53.5, 52.6, 
31.6; HRMS C26H25NO5 Calculated = 431.1733, Found = 431.1736 
 
 
Diethyl 2,3,6-triphenyl-1,2-oxazinane-4,4-dicarboxylate (35e) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34c (50 mg, 
0.19 mmol), nitrosobenzene (10 mg, 0.095 mmol) and Yb(OTf)3 (12 mg, 0.019 mmol) to yield the 
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (28 
mg, 62%). Rf 0.46 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.55 - 7.60 (m, 4 H), 7.47 
(app t, J = 7.2 Hz, 2 H), 7.38 - 7.41 (m, 1 H), 7.09 - 7.20 (m, 7 H), 6.81 (app tt, J = 7.0, 1.6 Hz, 1 
H), 5.79 (s, 1 H), 5.03 (dd, J = 12.1, 2.3 Hz, 1 H), 4.40 (q, J = 7.0 Hz, 2 H), 3.83 - 3.99 (dddd, J = 
7.0, 7.0, 7.0, 10.5 Hz, 2 H), 2.87 (dd, J = 14.5, 12.1 Hz, 1 H), 2.79 (dd, J = 14.5, 2.3 Hz, 1 H), 1.37 
(t, J = 7.2 Hz, 3 H), 1.03 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 169.6, 167.9, 148.6, 
139.6, 135.0, 130.6, 128.6, 128.5, 128.2, 128.0, 127.9, 126.4, 121.5, 115.8, 78.8, 65.8, 62.3, 61.8, 
59.3, 31.9, 14.2, 13.7; HRMS C28H29NO5 Calculated = 459.2046, Found = 459.2027 
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Dimethyl 2-phenyl-3,6-di-p-tolyl-1,2-oxazinane-4,4-dicarboxylate (35f) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34b (50 mg, 
0.20 mmol), nitrosobenzene (11 mg, 0.10 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the 
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (21 
mg, 46%). Rf  0.60 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.45 - 7.48 (m, 4 H), 7.27 
(app d, J = 8.2 Hz, 2 H), 7.07 - 7.14 (m, 4 H), 6.99 (app d, J = 7.8 Hz, 2 H), 6.80 (app tt, J = 8.2, 
1.2 Hz, 1 H), 5.76 (s, 1 H), 4.98 (dd, J = 12.1, 2.3 Hz, 1 H), 3.91 (s, 3 H), 3.50 (s, 3 H), 2.86 (dd, 
J = 14.5, 12.1 Hz, 1 H), 2.74 (dd, J = 14.5, 2.3 Hz, 1 H), 2.41 (s, 3 H), 2.22 (s, 3 H); 13C NMR (100 
MHz, CDCl3) 170.2, 168.4, 148.6, 143.0, 138.2, 137.6, 136.4, 131.9, 130.3, 129.7, 129.5, 129.3, 
129.2, 128.7, 128.5, 126.6, 126.5, 121.4, 115.7, 78.7, 65.3, 59.6, 53.4, 52.6, 31.4, 21.3, 21.1; 
HRMS C28H29NO5 Calculated = 459.2046, Found = 459.2027 
 
Dimethyl 2-phenyl-3,6-di(thiophen-2-yl)-1,2-oxazinane-4,4-dicarboxylate (35g) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34e (100 mg, 
0.42 mmol), nitrosobenzene (121 mg, 0.20 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the 
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (61 
mg, 69%). Rf  0.39 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.40 (app d, J = 5.1 Hz, 1 
H), 7.25 (app d, J = 3.9 Hz, 1 H), 7.15 - 7.20 (m, 3 H), 7.06 - 7.13 (m, 3 H), 6.95 (app d, J = 3.5 
Hz, 1 H), 6.88 (app t, J = 7.4 Hz, 1 H), 6.80 - 6.84 (m, 1 H), 6.09 (s, 1 H), 5.27 (dd, J = 12.1, 2.3 
Hz, 1 H), 3.92 (s, 3 H), 3.59 (s, 3 H), 2.99 (dd, J = 14.5, 12.1 Hz, 1 H), 2.88 (dd, J = 14.5, 2.3 Hz, 
1 H); 13C NMR (100 MHz, CDCl3) 169.3, 167.7, 148.1, 141.5, 133.8, 129.2, 128.5, 127.2, 126.7, 
126.0, 125.8, 125.4, 122.4, 116.3, 75.0, 64.3, 59.7, 53.6, 52.9, 32.3; HRMS C22H21NO5S2 
Calculated = 443.0861, Found = 443.0864 
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Dimethyl 2-(3-bromophenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44a) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (100 mg, 
0.43 mmol), nitrosoarene (20 mg, 0.11 mmol) and Yb(OTf)3 (6 mg, 0.010 mmol) to yield the 
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (41 
mg, 73%). Rf  0.38 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.54 - 7.60 (m, 4 H), 7.46 
- 7.50 (m, 2 H), 7.40 - 7.43 (m, 1 H), 7.22 - 7.24 (m, 3 H), 6.99 - 7.01 (m, 2 H), 6.91 - 6.94 (m, 1 
H), 5.76 (s, 1 H), 4.99 (dd, J = 12.1, 2.3 Hz, 1 H), 3.92 (s, 3 H), 3.49 (s, 3 H), 2.87 (dd, J = 14.5, 
12.1 Hz, 1 H), 2.76 (dd, J = 14.5, 2.3 Hz, 1 H); 13C NMR (100 MHz, CDCl3) 169.9, 168.0, 138.9, 
134.5, 130.2, 129.9, 128.7, 128.5, 128.3, 128.2, 126.6, 124.4, 122.7, 118.6, 114.0, 79.1, 59.4, 53.6, 
52.7; HRMS C26H24BrNO5 Calculated = 509.0838, Found = 509.0823 
 
 
Dimethyl 2-(4-bromophenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44b) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (100 mg, 
0.43 mmol), nitrosoarene (37 mg, 0.20 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the 
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (75 
mg, 75%). Rf  0.34 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.53 - 7.57 (m, 4 H), 7.45 
- 7.47 (m, 2 H), 7.38 - 7.42 (m, 1 H), 7.18 - 7.20 (m, 5 H), 6.96 - 6.98 (m, 2 H), 5.73 (s, 1 H), 5.00 
(dd, J = 12.1, 2.7 Hz, 1 H), 3.92 (s, 3 H), 3.48 (s, 3 H), 2.87 (dd, J = 14.5, 12.1 Hz, 1 H), 2.76 (dd, 
J = 14.5, 2.7 Hz, 1 H); 13C NMR (100 MHz, CDCl3) 168.1, 147.6, 139.0, 134.6, 131.4, 130.3, 
128.7, 128.5, 128.3, 128.1, 126.5, 117.5, 114.1, 79.0, 65.6, 59.4, 53.6, 52.7, 31.5; HRMS 
C26H24BrNO5 Calculated = 509.0838, Found = 509.0830 
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Dimethyl 2-(3-(ethoxycarbonyl)phenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44c) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (100 mg, 
0.43 mmol), nitrosoarene (39 mg, 0.22 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the 
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (88 
mg, 80%). Rf 0.29 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.75 (app t, J = 1.6 Hz, 1 
H), 7.55 - 7.62 (m, 4 H), 7.45 - 7.51 (m, 3 H), 7.39 - 7.43 (m, 1 H), 7.27 - 7.32 (m, 1 H), 7.17 - 
7.22 (m, 4 H), 5.85 (s, 1 H), 5.02 (dd, J = 12.1, 2.3 Hz, 1 H), 4.32 (q, J = 7.0 Hz, 2 H), 3.93 (s, 3 
H), 3.49 (s, 3 H), 2.90 (dd, J = 14.5, 12.1 Hz, 1 H), 2.77 (dd, J = 14.5, 2.3 Hz, 1 H), 1.35 (t, J = 7.2 
Hz, 3 H); 13C NMR (100 MHz, CDCl3) 170.0, 168.1, 166.6, 148.6, 139.1, 134.6, 130.4, 128.7, 
128.6, 128.4, 128.2, 128.1, 126.5, 122.6, 120.1, 116.6, 79.0, 65.3, 60.9, 59.4, 53.6, 52.7, 31.6, 14.3; 
HRMS C29H29NO7 Calculated = 503.1944, Found = 503.1943 
 
 
Dimethyl 2-(4-(ethoxycarbonyl)phenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44d) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (106 mg, 
0.45 mmol), nitrosoarene (36 mg, 0.20 mmol) and Yb(OTf)3 (17 mg, 0.027 mmol) to yield the 
compound as a yellow oil, which was recrystallized to give a white solid (78 mg, 78%). Rf  0.28 
(3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.82 - 7.86 (m, 2 H), 7.54 - 7.61 (m, 4 H), 7.46 
- 7.51 (m, 2 H), 7.40 - 7.45 (m, 1 H), 7.19 - 7.24 (m, 3 H), 7.09 - 7.13 (m, 2 H), 5.91 (s, 1 H), 5.00 
(dd, J = 12.1, 2.3 Hz, 1 H), 4.27 (q, J = 7.0 Hz, 2 H), 3.92 (s, 3 H), 3.50 (s, 3 H), 2.90 (dd, J = 14.5, 
12.1 Hz, 1 H), 2.77 (dd, J = 14.5, 2.3 Hz, 1 H), 1.32 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) 169.9, 168.0, 166.4, 151.9, 138.7, 134.7, 130.6, 130.0, 128.8, 128.6, 128.4, 128.2, 126.6, 
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122.8, 114.2, 79.1, 64.4, 60.5, 53.6, 52.8, 31.5, 14.3; HRMS C29H29NO7 Calculated = 503.1944, 
Found = 503.1943 
 
Dimethyl 2-(3,4-dichlorophenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44e) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (57 mg, 
0.24 mmol), nitrosoarene (19 mg, 0.11 mmol) and Yb(OTf)3 (6 mg, 0.010 mmol) to yield the 
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (50 
mg, 91%). Rf  0.55 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.53 - 7.58 (m, 4 H), 7.46 
- 7.50 (m, 2 H), 7.40 - 7.44 (m, 1 H), 7.22 - 7.25 (m, 3 H), 7.17 - 7.19 (m, 2 H), 6.89 - 6.92 (app 
dd, J = 9.0, 2.7 Hz, 1 H), 5.72 (s, 1 H), 4.98 (dd, J = 12.3, 2.4 Hz, 1 H), 3.92 (s, 3 H), 3.48 (s, 3 H), 
2.87 (dd, J = 14.7, 12.3 Hz, 1 H), 2.74 (dd, J = 14.7, 2.4 Hz, 1 H); 13C NMR (100 MHz, CDCl3) 
167.9, 147.9, 138.7, 134.3, 132.5, 130.2, 130.1, 128.8, 128.7, 128.5, 128.3, 126.6, 124.5, 117.5, 
114.9, 79.3, 65.3, 59.2, 53.6, 52.8, 31.4; HRMS C26H23Cl2NO5 Calculated = 499.0953, Found = 
499.0952 
 
Dimethyl 2-(3-acetylphenyl)-3,6-diphenyl-1,2-oxazinane-4,4-dicarboxylate (44f) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (100 mg, 
0.43 mmol), nitrosoarene (32 mg, 0.21 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the 
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (68 
mg, 68%). Rf  0.25 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 7.64 - 7.67 (m, 1 H), 7.55 
- 7.62 (m, 4 H), 7.46 - 7.50 (m, 2 H), 7.39 - 7.43 (m, 2 H), 7.30 - 7.34 (m, 1 H), 7.24 - 7.26 (m, 1 
H), 7.18 - 7.22 (m, 3 H), 5.85 (s, 1 H), 5.03 (dd, J = 12.1, 2.3 Hz, 1 H), 3.93 (s, 3 H), 3.49 (s, 3 H), 
2.89 (dd, J = 14.5, 12.1 Hz, 1 H), 2.79 (dd, J = 14.5, 2.3 Hz, 1 H), 2.50 (s, 3 H); 13C NMR (100 
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MHz, CDCl3) 170.0, 168.1, 148.8, 137.5, 134.6, 130.3, 128.8, 128.7, 128.5, 128.3, 128.1, 126.5, 
121.7, 120.5, 115.1, 79.1, 65.3, 59.4, 53.6, 52.7, 31.6, 26.7; HRMS C28H27NO6 Calculated = 
473.1838, Found = 473.1829 
 
Dimethyl 2-(1-(tert-butoxycarbonyl)-1H-indol-5-yl)-3,6-diphenyl-1,2-oxazinane-4,4-
dicarboxylate (44g) 
The general Lewis acid cycloaddition procedure was followed using cyclopropane 34a (50 mg, 
0.21 mmol), nitrosoarene (27 mg, 0.11 mmol) and Yb(OTf)3 (12 mg, 0.020 mmol) to yield the 
compound as a yellow oil, which was recrystallized with CH2Cl2/Hexane to give a white solid (35 
mg, 55%). Rf  0.40 (3:1 Hexanes:EtOAc); 1H NMR (400 MHz, CDCl3) 8.04 - 8.06 (m, 1 H), 7.56 
- 7.61 (m, 4 H), 7.46 - 7.50 (m, 4 H), 7.39 - 7.42 (m, 1 H), 7.26 - 7.27 (m, 1 H), 7.14 - 7.18 (m, 2 
H), 7.10 - 7.13 (app dd, J = 9.0, 2.3 Hz, 1 H), 6.38 (app d, J = 3.5 Hz, 1 H), 5.78 (s, 1 H), 5.10 (dd, 
J = 12.1, 2.3 Hz, 1 H), 3.96 (s, 3 H), 3.47 (s, 3 H), 2.90 (dd, J = 14.5, 12.1 Hz, 1 H), 2.80 (dd, J = 
14.5, 2.3 Hz, 1 H), 1.61 (s, 9 H); 13C NMR (100 MHz, CDCl3) 170.2, 168.3, 166.2, 144.5, 139.6, 
134.9, 131.0, 130.5, 128.8, 128.6, 128.4, 128.3, 128.0, 127.9, 126.6, 114.9, 107.4, 78.8, 67.3, 59.6, 
53.8, 53.5, 52.6, 31.7, 28.2; HRMS C33H34N2O7 Calculated = 570.2366, Found = 570.2347 
 
General Lewis Acid Catalyzed Cross-Over Experiment Procedure 
 
To a solution of cyclopropane 34a (0.43 mmol, 1.0 equiv) and cyclopropane 34d (0.43 
mmol, 1.0 equiv) and nitrosobenzene 32a (0.43 mmol, 1.0 equiv) in DCE (3 mL) was added 
Yb(OTf)3 (0.043 mmol, 0.1 equiv) and stirred for 15 min. The mixture was heated to reflux for 3 
h then concentrated after consumption of cyclopropane (as indicated by TLC) and directly loaded 
onto a packed SiO2 column. The products were purified by flash chromatography (9:1 
hexanes/EtOAc). 
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Chapter 3 - Cycloadditions of Donor-Acceptor Cyclopropanes with Azo Dicarboxylates 
 
3.1 Introduction 
 
In 2007, Armin de Meijer reported the successful reaction between cyclopropanes and azo 
dicarboxylates, which give rise to pyrazolidine derivatives (Scheme 3.1).  After testing several 
Lewis acids, GaCl3 was found to catalyze the reaction, and only trace amounts of product were 
formed using Yb(OTf)3. When trans-configured diazenes are used, insertion into the cyclopropane 
ring proceeds with complete regioselectivity to produce the expected 5-arylpyrazolidine-1,2,3,3-
tetracarboxylates. The trans-configured diazenes used were naturally existing mixtures of minor 
amounts of cis- and major amounts of the thermodynamically favoured trans-diastereomers. The 
reactivity of cyclopropanes towards a fixed cis-configuration of the N,N double bond was also 
investigated. Interestingly, when 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD) was used as a cis-
configured diazene, two possible regioisomeric pyrazolidine derivatives were formed in ratios 
varying from 1:1.5 to 1:3.22 
 
Scheme 3.1 Cycloaddition of DA cyclopropanes with azo dicarboxylates 
 
3.2 Cycloadditions of DA Cyclopropanes with trans-Diazenes 
 
The [3+2] cycloaddition reaction of cyclopropanes with trans-configured diazenes as seen 
in Scheme 3.2 was examined in order to investigate the mechanism and hopefully provide a deeper 
understanding of how cyclopropanes react with nitrogen-heteroatom double bonded compounds. 
This mode of reactivity may show resemblance to the opening of cyclopropanes with 
nitrosoarenes, so a cross-over experiment was performed in order to probe the mechanism of the 
following reaction. 
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Scheme 3.2 Cycloaddition of DA cyclopropanes with trans-diazenes 
 
3.2.1 Cross-Over Experiment #2 
 
To obtain experimental evidence that trans-configured diazenes open the cyclopropane 
ring in a nucleophilic manner, paralleling what happens with nitrosoarenes, a cross-over 
experiment would have to contain two different cyclopropanes in order to show that a cross-over 
event occurred. For this cross-over experiment, four different cyclopropanes were used so that four 
different pyrazolidine standards could be generated, accounting for the possible cross-over based 
products (Table 3.1). After obtaining the four pyrazolidine standards, the cross-over experiment 
was performed and the reaction mixture was analyzed. 
 
Table 3.1 Cycloaddition of DA cyclopropanes with trans-diazenes 
 
Entrya Cyclopropane Product Yield (%)b 
1 Ar = C6H5, R = Me 48a 58 
2 Ar = 4-MeC6H4, R = Me 48b 50 
3 Ar = C6H5, R = Et 48c 23 
4 Ar = 4-MeC6H4, R = Et 48d 52 
 a Typical reaction conditions: To a solution of GaCl3 in CH2Cl2 (0.8 mL) at room 
temperature, was added cyclopropane (0.21 mmol) and trans-diazene (0.29 mmol). 
Reactions were monitored by TLC until cyclopropane was consumed. b Isolated 
yield. 
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Separation of the reaction mixture was performed using column chromatography and only 
two products had formed, as seen in Scheme 3.3. 
 
Scheme 3.3 Cross-over experiment of DA cyclopropanes with trans-diazenes 
 
The expected [3+2] cycloaddition products were observed with no cross-over. This 
provides evidence of a straight forward [3+2] cycloaddition with nothing unusual observed with 
trans-diazenes. 
 
3.3 Cycloadditions of DA Cyclopropanes with cis-Diazenes 
 
The cycloaddition product from DA cyclopropane and cis-configured diazene PTAD 
produces an unusual pyrazolidine derivative, which may have arisen from insertion into the C(2)-
C(3) bond of the cyclopropane (Scheme 3.4). Because of this surprisingly different mode of 
cyclopropane reactivity, the reaction of DA cyclopropanes with trans-diazenes must operate 
through a different type of mechanism than cis-diazenes. A cross-over experiment was performed 
to investigate how this unusual pyrazolidine derivative product was formed. Understanding how 
cyclopropanes can undergo this rare insertion into the C(2)-C(3) bond would be useful for its 
application in synthesis. 
 
Scheme 3.4 Cycloaddition of DA cyclopropanes with cis-diazenes 
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 A mechanism was proposed by de Meijer to account for the unusual reactivity of the DA 
cyclopropane when it encounters the Lewis activated cis-diazene (Figure 3.1). It would be very 
difficult to prove how this reaction proceeds without the use of a cross-over experiment. 
 
 
 
Figure 3.1 Proposed mechanism for the cycloaddition of DA cyclopropane with cis-diazene 
 
PTAD was synthesized according to Scheme 3.5 for use in a cross-over experiment and 
also to generating standards used to analyze the reaction mixture. 
 
 
 
Scheme 3.5 Synthesis of PTAD 
 
The cycloaddition of DA cyclopropanes with cis-diazenes was investigated so that it may 
be applied to understanding and advancing the nitrosoarene chemistry if experimental evidence 
suggests similarities. Possible reaction mechanisms that accounts for both products are shown in 
Scheme 3.6 and 3.7, demonstrating a possible resemblance to the cycloaddition of DA 
cyclopropanes with nitrosoarene mechanism. The first mechanism shows the cycloaddition leading 
to the minor product operating through a step-wise sequence. 
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Scheme 3.6 Proposed mechanism for the formation of minor product 50a 
 
 
 
Scheme 3.7 Proposed mechanism for the formation of major product 51a 
 
Co-ordination of Yb(OTf)3 to the di-ester group on the cyclopropane may allow for a 
nucleophilic ring opening attack from a nitrogen in PTAD. The mechanism in scheme 3.6 shows 
formation of the minor product going through a step-wise cyclization, once the acyclic zwitterionic 
intermediate is formed. Because the presented cyclization is going through a 5-Endo-Trig reaction, 
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which is disallowed according to Baldwin’s rules, the cyclization may be going through a 
concerted cycloaddition. Scheme 3.7 and 3.8 illustrate that production of the major product may 
occur through the formation of an azomethine imine intermediate (57).  
The formation of azomethine imines through the reaction of DA cyclopropanes with cis-
diazenes has been of interest in the Pagenkopf group and experimental evidence supporting this 
theory would be of interest not only for understanding the reaction, but in the future development 
of new reaction types and reaction partners with DA cyclopropanes. 
 
 
 
Scheme 3.8 Formation of the two different pyrazolidine regio-isomers 
 
Major product 51a must be coming from azomethine imine 57, which would have a slightly 
higher degree of stability or population in comparison to the resonance structure 57a (Scheme 3.8). 
The resonance structure, in which the negative charge ends up on nitrogen instead of carbon, would 
be the more favoured intermediate (57) and would therefore contribute to the major product, which 
is observed to be the case. A resonance structure that places a negative charge on carbon of the 
azomethine imine (57a) is possible, but is not considered to be a nucleophilic centre based on the 
regio-selectivity of other observed azomethine imine reactions. It is therefore highly unlikely that 
the minor product would be occurring through this type of pathway, and is most likely the result 
of a formal [3+2] cycloaddition with azomethine imine 57. 
This mode of reactivity would require only one equivalent of DA cyclopropane to one 
equivalent of the cis-diazene because the α,β-unsaturated di-ester may be incorporated into the 
product. This is slightly different than the nitrosoarene reaction with DA cyclopropanes, because 
the α,β-unsaturated di-ester is just a by-product and is not incorporated into the tetrahydro-1,2-
oxazine product. It is worth determining if the minor product is formed from incorporation of the 
α,β-unsaturated di-ester unit, or if it is simply a straight-forward cyclization as presented in scheme 
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2.6. The use of a cross-over experiment would be of great benefit in helping to answer how the 
two different regio-isomers are formed. 
Understanding the different ways that DA cyclopropanes react with various dipolarophiles 
has been undertaken with the hope of developing better and more efficient methods of generating 
diverse heterocycles. Developing reactions than are able to insert different functional groups into 
the C(2)-C(3) bond of the cyclopropane ring would have many advantages, and understanding this 
rare type of reactivity is currently being investigated with the use of cross-over experiments. Being 
able to open the cyclopropane ring in a controlled manner that allows for different regio-isomers 
to from is attractive and expands the use of DA cyclopropanes in synthetic chemistry. 
 
3.3.1 Cross-over Experiment #3 
 
Two different cyclopropanes were used as starting material and reacted with PTAD under 
GaCl3 catalytic conditions (Scheme 3.9). The production of a cross-over based pyrazolidine 
product would give information about how this reaction mechanism is happening. If results show 
the presence of a pyrazolidine product, in which cross-over has occurred, then the reaction may be 
taking place in a way that is similar to the cycloaddition of DA cyclopropanes with nitrosoarenes 
reaction. 
 
 
 
Scheme 3.9 Cross-over experiment of DA cyclopropanes with cis-diazenes 
 
The four products shown in Figure 3.2 are expected to be in the reaction mixture of the 
cross-over experiment. These products would arise from the known reactivity of the two DA 
cyclopropanes reacting with PTAD, and show no crossing-over. 
39 
 
 
 
 
 
Figure 3.2 Expected products from the cross-over experiment 
 
If additional products are formed, showing that cross-over had occurred, then this provides 
mechanistic information that would be helpful in generating a theoretical mechanism with 
supporting evidence. Formation of any of the products shown in Figure 3.3 would be the result of 
a cross-over event happening in the reaction. 
 
 
 
Figure 3.3 Proposed cross-over based products from the cross-over experiment 
 
If DA cyclopropanes react with nitrosoarenes and cis-diazenes in a similar fashion, in 
which a nitrogen-heteroatom double bond opens up the cyclopropane ring, and can be reinforced 
with experimental evidence, then other reaction types may be discovered by investigating this 
mode of reactivity. I synthesized the required pyrazolidine standards individually using the 
methodology presented in de Meijer’s study. Table 3.2 shows the synthesis of 8 pyrazolidine 
standards, which were then used as authentic standards in cross-over experiment #3. 
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Table 3.2 Synthesis of pyrazolidine standards 
 
 
 
Entrya Cyclopropane Product Yield (%)b 
1 Ar = C6H5, R = Me 50a 13 
2 Ar = C6H5, R = Me 51a 20 
3 Ar = C6H5, R = Et 50b 19 
4 Ar = C6H5, R = Et 51b 22 
5 Ar = 4-MeC6H4, R = Me 50c 21 
6 Ar = 4-MeC6H4, R = Me 51c 12 
7 Ar = 4-MeC6H4, R = Et 50d 12 
8 Ar = 4-MeC6H4, R = Et 51d 12 
a Typical reaction conditions: GaCl3 was added to a solution of cyclopropane 
(0.21 mmol) and PTAD (0.21 mmol) in CH2Cl2 (0.2 mL). Reactions were 
monitored by TLC. b Isolated yield. 
 
 
 A detailed analysis of the products from cross-over experiment #3, as seen in Figure 3.4, 
was achieved with the use of NMR and GC-MS. After carefully analyzing the reaction mixture of 
the cross-over experiment, it was revealed that all four expected products were formed and, in 
addition, two of the cross-over products were also formed, yielding six products in total. 
 
 
 
41 
 
 
 
 
 
Figure 3.4 Results of cross-over experiment #3 
 
 Formation of the cross-over based products provide key mechanistic information that is in 
agreement with the reaction proceeding via an azomethine imine as illustrated in Scheme 3.7. The 
azomethine imine can react with either the dimethyl or diethyl α,β-unsaturated ester to yield 51c 
or 51b, respectively. The absence of the other cross-over based products from the reaction mixture 
is in agreement with the proposed mechanism. 
 
3.3.2 Cross-over Experiment #3 Reversed 
 
 To achieve additional supporting evidence, the reaction was run in reverse, starting with 
cross-over based cyclopropanes (Scheme 3.10) and observing the reaction mixture to see if cross-
over was happening in a reproducible event. The reverse cross-over experiment was repeated three 
times to provide reinforcing data, as seen in Figure 3.5. This generated reproducible results that 
are in agreement with the original proposed mechanism. 
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Scheme 3.10 Reversed cross-over experiment of DA cyclopropanes with cis-diazenes 
 
 
Figure 3.5 Results of reversed cross-over experiment #3 
 
 The results from cross-over experiments 1 and 3 (Scheme 3.11 and 3.12) show similarities 
in the reaction of 1,1-cyclopropane diesters with nitrosoarenes and cis-diazenes. The overall 
pattern of reactivity is the same as both reactions led to the production of a 1,3-dipole intermediate. 
In the case of nitrosoarenes, a nitrone was produced. In the case of cis-diazenes, an azomethine 
imine was produced. In both cases the functional group is a nitrogen-heteroatom double bond, with 
a lone pair on nitrogen attacking as a nucleophile to open up the activated DA cyclopropane. The 
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resulting intermediate undergoes fragmentation forming a 1,3-dipole and an α,β-unsaturated 
diester. 
 
Scheme 3.11 Reaction of nitrosoarenes and cis-diazenes with DA cyclopropanes 
 
 
Scheme 3.12 Mechanistic formation of 1,3-dipoles 
Additional experimentation may show that other heteroatoms could react in a similar 
fashion, paving the way for new reactions and other reaction partners for DA cyclopropanes. In 
the case of nitrogen, which is a Group 5 element, trying elements in the same column such as 
phosphorus, may lead to new reactions because of similarities in the electronic structure of the two 
elements. 
A potential avenue for investigation could include obtaining a compound  with a nitrogen-
phosphorus double bond and observing the ability of the sp2 hybridized nitrogen to undergo 
nucleophilic opening of a DA cyclopropane ring, followed by fragmentation into a 1,3-dipole and 
an α,β-unsaturated diester. A proper Lewis Acid would be needed to activate the DA cyclopropane, 
with the idea of undergoing a reaction similar to Scheme 3.12, except using X = phosphorus. 
Another experiment could attempt trying elements in the same column as oxygen, such as 
sulfur. Obtaining a compound with a nitrogen-sulfur double bond would allow for reactions to 
study the nucleophilicity of the sp2 hybridized nitrogen towards the opening of DA cyclopropane 
rings upon activation by Lewis Acids, similar to Scheme 2.12, except using X = sulfur. 
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3.4 Experimental 
 
 The procedures and conditions were the same as described in section 2.3. 
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3.5 Supporting Information 
 
General trans-Diazene Cycloaddition Procedure 
 To a solution of cyclopropane (0.21 mmol, 1.0 equiv) and diisopropyl azodicarboxylate 
(0.29 mmol, 1.4 equiv) in CH2Cl2 (0.2 mL) was added a solution of GaCl3 (0.04 mmol, 0.2 equiv) 
in CH2Cl2 (0.8 mL). After stirring for 3 h, the crude mixture was concentrated and directly loaded 
onto a packed SiO2 column. Product was purified by flash chromatography (8:1 hexanes/EtOAc) 
to afford the corresponding cycloadducts. 
 
 
1,2-Diisopropyl 3,3-dimethyl 5-phenylpyrazolidine-1,2,3,3-tetracarboxylate (48a) 
The general trans-diazene cycloaddition procedure was followed using cyclopropane 34a (50 mg, 
0.21 mmol), diisopropyl azodicarboxylate 47 (59 mg, 0.29 mmol) and GaCl3 (7 mg, 0.040 mmol) 
to yield the compound as a yellow oil (53 mg, 58%). Rf 0.22 (3:1 Hexanes:EtOAc); 1H NMR (400 
MHz, CDCl3) 7.39 (app d, J = 7.8 Hz, 2 H), 7.29 - 7.34 (m, 2 H), 7.22 - 7.26 (m, 1 H), 5.46 (dd, J 
= 8.2, 3.9 Hz, 1 H), 5.02 (hept, J = 6.3 Hz, 1 H), 4.97 (hept, J = 6.3 Hz, 1 H), 3.82 (s, 3 H), 3.47 
(s, 3 H), 3.30 (dd, J = 13.3, 8.2 Hz, 1 H), 2.92 (dd, J = 13.3, 3.9 Hz, 1 H), 1.24 - 1.30 (m, 12 H); 
13C NMR (100 MHz, CDCl3) 168.8, 166.5, 156.9, 153.3, 139.5, 128.3, 127.3, 125.8, 72.4, 70.8, 
70.5, 61.2, 53.4, 53.0, 44.7, 22.1, 21.9; HRMS C21H28N2O8 Calculated = 436.1846, Found = 
436.1841 
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1,2-Diisopropyl 3,3-dimethyl 5-p-tolylpyrazolidine-1,2,3,3-tetracarboxylate (48b) 
The general trans-diazene cycloaddition procedure was followed using cyclopropane 34b (55 mg, 
0.22 mmol), diisopropyl azodicarboxylate 47 (63 mg, 0.31 mmol) and GaCl3 (7 mg, 0.040 mmol) 
to yield the compound as a yellow oil (50 mg, 50%). Rf 0.25 (3:1 Hexanes:EtOAc); 1H NMR (400 
MHz, CDCl3) 7.27 (app d, J = 8.2 Hz, 2 H), 7.12 (app d, J = 8.2 Hz, 2 H), 5.40 (dd, J = 8.2, 4.3 
Hz, 1 H), 5.01 (hept, J = 6.3 Hz, 1 H), 4.98 (hept, J = 6.3 Hz, 1 H), 3.82 (s, 3 H), 3.51 (s, 3 H), 
3.27 (dd, J = 13.3, 8.2 Hz, 1 H), 2.90 (dd, J = 13.3, 4.3 Hz, 1 H), 2.32 (s, 3 H), 1.24 - 1.30 (m, 12 
H); 13C NMR (100 MHz, CDCl3) 168.8, 166.4, 156.9, 153.4, 136.9, 136.5, 129.0, 125.8, 72.5, 
70.7, 70.5, 61.0, 53.4, 53.0, 44.7, 22.1, 21.9; HRMS C22H30N2O8 Calculated = 450.2002, Found = 
450.1999 
 
 
3,3-Diethyl 1,2-diisopropyl 5-phenylpyrazolidine-1,2,3,3-tetracarboxylate (48c) 
The general trans-diazene cycloaddition procedure was followed using cyclopropane 34c (50 mg, 
0.19 mmol), diisopropyl azodicarboxylate 47 (55 mg, 0.27 mmol) and GaCl3 (7 mg, 0.040 mmol) 
to yield the compound as a yellow oil (20 mg, 23%). Rf 0.30 (3:1 Hexanes:EtOAc); 1H NMR (400 
MHz, CDCl3) 7.38 - 7.42 (m, 2 H), 7.29 - 7.33 (m, 2 H), 7.22 - 7.25 (m, 1 H), 5.50 (dd, J = 8.2, 
3.5 Hz, 1 H), 5.02 (hept, J = 6.3 Hz, 1 H), 4.98 (hept, J = 6.3 Hz, 1 H), 4.29 (dddd, J = 7.0, 7.0, 
7.0, 10.5 Hz, 2 H), 3.90 (dddd, J = 7.2, 7.2, 7.2, 10.8 Hz, 2 H), 3.33 (dd, J = 13.3, 8.6 Hz, 1 H), 
2.90 (dd, J = 13.3, 3.1 Hz, 1 H), 1.24 - 1.34 (m, 15 H), 0.91 (t, J = 7.0 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) 168.2, 166.2, 156.9, 153.1, 139.7, 128.3, 127.2, 125.8, 72.3, 70.8, 70.4, 62.4, 62.1, 
61.2 44.5, 22.1, 21.9, 21.7, 14.0, 13.3; HRMS C23H32N2O8 Calculated = 464.2159, Found = 
464.2167 
47 
 
 
 
 
3,3-Diethyl 1,2-diisopropyl 5-(p-tolyl)pyrazolidine-1,2,3,3-tetracarboxylate (48d) 
The general trans-diazene cycloaddition procedure was followed using cyclopropane 34d (50 mg, 
0.18 mmol), diisopropyl azodicarboxylate 47 (51 mg, 0.25 mmol) and GaCl3 (6 mg, 0.036 mmol) 
to yield the compound as a yellow oil (45 mg, 52%). Rf 0.31 (3:1 Hexanes:EtOAc); 
1H NMR (400 
MHz, CDCl3) 7.28 (app d, J = 8.2 Hz, 2 H), 7.11 (app d, J = 8.2 Hz, 2 H), 5.45 (dd, J = 8.2, 3.5 
Hz, 1 H), 5.01 (hept, J = 6.3 Hz, 1 H), 4.97 (hept, J = 6.3 Hz, 1 H), 4.28 (dddd, J = 7.0, 7.0, 7.0, 
10.5 Hz, 2 H), 3.93 (dddd, J = 7.2, 7.2, 7.2, 10.8 Hz, 2 H), 3.29 (dd, J = 13.3, 8.2 Hz, 1 H), 2.88 
(dd, J = 13.3, 3.5 Hz, 1 H), 2.31 (s, 3 H), 1.23 - 1.34 (m, 15 H), 0.95 (t, J = 7.0 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) 168.2, 166.2, 156.9, 153.2, 136.8, 136.7, 128.9, 125.8, 72.4, 70.7, 70.3, 62.4, 
62.2, 61.0, 44.5, 22.1, 21.9, 21.0, 14.0, 13.3; HRMS C24H34N2O8 Calculated = 478.2315, Found = 
478.2321 
 
 
(PTAD) 4-Phenyl-1,2,4-trizaoline-3,5-dione (49) 
tert-Butyl hypochlorite (130 mg, 1.2 mmol, 1.1 equiv) was added drop wise with stirring to a 
solution of 4-phenyl-1,2,4-trizaolidine-3,5-dione (200 mg, 1.1 mmol, 1.0 equiv) in 1,4-dioxane (5 
mL). After 30 min the solvent was removed under reduced pressure keeping the temp below 40°C 
to yield the product as a red solid (200 mg, 99%). 1H NMR (400 MHz, CDCl3) 7.46 - 7.59 (m, 5 
H); 13C NMR (100 MHz, CDCl3) 129.9, 129.5, 123.9 
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General cis-Diazene Cycloaddition Procedure 
 To a solution of cyclopropane (0.85 mmol, 1.0 equiv) and PTAD (1.7 mmol, 2.0 equiv) in 
CH2Cl2 (4.0 mL) was added a solution of GaCl3 (0.17 mmol, 0.2 equiv) in CH2Cl2 (1.0 mL). After 
stirring for 3 h, the crude mixture was concentrated and directly loaded onto a packed SiO2 column. 
Product was purified by flash chromatography (8:1 hexanes/EtOAc) to afford the corresponding 
cycloadducts. 
 
 
Dimethyl 1,3-dioxo-2,7-diphenyltetrahydropyrazolo[1,2-a][1,2,4]triazole-5,5(1H)-
dicarboxylate (50a) 
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34a (200 mg, 
0.85 mmol), cis-diazene 49 (298 mg, 1.7 mmol) and GaCl3 (30 mg, 0.17 mmol) to yield the 
compound as a white solid (45 mg, 13%). Rf  0.40 (3:1 Hexanes:EtOAc); 
1H NMR (400 MHz, 
CDCl3) 7.51 - 7.55 (m, 2 H), 7.33 - 7.47 (m, 8 H), 5.19 (dd, J = 9.0, 7.4 Hz, 1 H), 3.92 (s, 3 H), 
3.87 (s, 3 H), 3.28 (d, J = 3.1 Hz, 1 H), 3.25 (d, J = 5.1 Hz, 1 H); 13C NMR (100 MHz, CDCl3) 
167.0, 165.7, 153.6, 136.6, 131.5, 129.1, 128.7, 128.3, 126.2, 125.7, 70.7, 59.3, 54.4, 54.0, 46.9; 
HRMS C21H19N3O6 Calculated = 409.1274, Found = 409.1264 
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Dimethyl 1,3-dioxo-2,5-diphenyltetrahydropyrazolo[1,2-a][1,2,4]triazole-6,6(1H)-
dicarboxylate (51a) 
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34a (200 mg, 
0.85 mmol), cis-diazene 49 (298 mg, 1.7 mmol) and GaCl3 (30 mg, 0.17 mmol) to yield the 
compound as a white solid (71 mg, 20%). Rf  0.45 (3:1 Hexanes:EtOAc); 
1H NMR (400 MHz, 
CDCl3) 7.48 - 7.50 (m, 4 H), 7.32 - 7.42 (m, 6 H), 5.85 (s, 1 H), 4.46 (d, J = 13.3 Hz, 1 H), 4.28 
(d, J = 13.3 H, 1 H), 3.81 (s, 3 H), 3.47 (s, 3 H); 13C NMR (100 MHz, CDCl3) 169.7, 164.8, 156.6, 
156.3, 134.9, 131.6, 129.2, 129.1, 128.7, 128.5, 127.3, 126.0, 66.0, 65.3, 54.1, 52.8, 49.8; HRMS 
C21H19N3O6 Calculated = 409.1274, Found = 409.1264 
 
Diethyl 1,3-dioxo-2,7-diphenyltetrahydropyrazolo[1,2-a][1,2,4]triazole-5,5(1H)-
dicarboxylate (50b) 
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34c (50 mg, 
0.19 mmol), cis-diazene 49 (67 mg, 0.38 mmol) and GaCl3 (7 mg, 0.040 mmol) to yield the 
compound as a white solid (16 mg, 19%). Rf  0.60 (1:1 Hexanes:EtOAc); 
1H NMR (600 MHz, 
CDCl3) 7.51 - 7.54 (m, 2 H), 7.43 - 7.45 (m, 4 H), 7.39 - 7.41 (m, 2 H), 7.33 - 7.36 (m, 2 H), 5.16 
(dd, J = 9.4, 7.6 Hz, 1 H), 4.37 (dddd, J = 7.0, 7.0, 7.0, 10.5 Hz, 2 H), 4.33 (q, J = 7.0 Hz, 2 H), 
3.27 (dd, J = 13.5, 7.6 Hz, 1 H), 3.25 (dd, J = 13.5, 8.8 Hz, 1 H), 1.33 (t, J = 7.0 Hz, 3 H), 1.31 (t, 
J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 166.6, 165.1, 153.5, 153.2, 136.8, 131.6, 129.1, 
129.0, 128.7, 128.2, 126.2, 125.7, 70.9, 63.8, 63.3, 59.2, 46.8, 14.0, 13.9; HRMS C23H23N3O6 
Calculated = 437.1587, Found = 437.1582 
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Diethyl 1,3-dioxo-2,5-diphenyltetrahydropyrazolo[1,2-a][1,2,4]triazole-6,6(1H)-
dicarboxylate (51b) 
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34c (50 mg, 
0.19 mmol), cis-diazene 49 (67 mg, 0.38 mmol) and GaCl3 (7 mg, 0.040 mmol) to yield the 
compound as a white solid (18 mg, 22%). Rf  0.70 (1:1 Hexanes:EtOAc); 
1H NMR (600 MHz, 
CDCl3) 7.45 - 7.51 (m, 4 H), 7.35 - 7.40 (m, 6 H), 5.84 (s, 1 H), 4.47 (d, J = 12.9 Hz, 1 H), 4.31 
(d, J = 12.9 Hz, 1 H), 4.23 - 4.31 (m, 2 H), 3.99 (dddd, J = 7.3, 7.3, 7.3, 10.9 Hz, 1 H), 3.83 (dddd, 
J = 7.0, 7.0, 7.0, 10.5 Hz, 1 H), 1.25 (t, J = 7.0 Hz, 3 H), 1.07 (t, J = 7.0 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) 164.4, 156.5, 135.1, 129.2, 129.0, 128.6, 128.4, 127.5, 125.9, 81.3, 65.9, 63.3, 62.2, 
49.8, 13.8, 13.6; HRMS C23H23N3O6 Calculated = 437.1587, Found = 437.1591 
 
Dimethyl 1,3-dioxo-2-phenyl-7-(p-tolyl)tetrahydropyrazolo[1,2-a][1,2,4]triazole-5,5(1H)-
dicarboxylate (50c) 
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34b (50 mg, 
0.20 mmol), cis-diazene 49 (70 mg, 0.40 mmol) and GaCl3 (7 mg, 0.040 mmol) to yield the 
compound as a white solid (18 mg, 21%). Rf  0.65 (1:1 Hexanes:EtOAc); 
1H NMR (600 MHz, 
CDCl3) 7.50 - 7.53 (m, 2 H), 7.42 - 7.45 (m, 2 H), 7.33 - 7.36 (m. 1 H), 7.32 (app d, J = 7.6 Hz, 2 
H), 7.20 (app d, J = 7.6 Hz, 2 H), 5.14 (dd, J = 8.2, 8.2 Hz, 1 H), 3.91 (s, 3 H), 3.87 (s, 3 H), 3.25 
(d, J = 8.2 Hz, 2 H), 2.35 (s, 3 H); 13C NMR (100 MHz, CDCl3) 167.0, 165.8, 153.5, 138.6, 131.6, 
129.7, 129.0, 128.2, 126.2, 125.7, 70.6, 59.2, 54.3, 54.0, 46.9, 21.1; HRMS C22H21N3O6 Calculated 
= 423.1430, Found = 423.1431 
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Dimethyl 1,3-dioxo-2-phenyl-5-(p-tolyl)tetrahydropyrazolo[1,2-a][1,2,4]triazole-6,6(1H)-
dicarboxylate (51c) 
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34b (50 mg, 
0.20 mmol), cis-diazene 49 (70 mg, 0.40 mmol) and GaCl3 (7 mg, 0.040 mmol) to yield the 
compound as a white solid (10 mg, 12%). Rf  0.72 (1:1 Hexanes:EtOAc); 
1H NMR (600 MHz, 
CDCl3) 7.48 - 7.49 (m, 4 H), 7.38 - 7.41 (m, 1 H), 7.17 - 7.23 (m, 4 H), 5.81 (s, 1 H), 4.46 (d, J = 
12.9 Hz, 1 H), 4.30 (d, J = 12.9 Hz, 1 H), 3.80 (s, 3 H), 3.49 (s, 3 H), 2.34 (s, 3 H); 13C NMR (100 
MHz, CDCl3) 169.7, 164.9, 156.2, 139.0, 131.9, 131.6, 129.3, 129.2, 128.4, 127.2, 125.9, 65.9, 
65.2, 54.0, 52.8, 49.8, 21.2; HRMS C22H21N3O6 Calculated = 423.1430, Found = 423.1431 
 
 
Diethyl 1,3-dioxo-2-phenyl-7-(p-tolyl)tetrahydropyrazolo[1,2-a][1,2,4]triazole-5,5(1H)-
dicarboxylate (50d) 
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34d (50 mg, 
0.18 mmol), cis-diazene 49 (63 mg, 0.36 mmol) and GaCl3 (6 mg, 0.036 mmol) to yield the 
compound as a white solid (10 mg, 12%). Rf  0.60 (5:1 Et2O:Pentane); 
1H NMR (400 MHz, CDCl3) 
7.50 - 7.54 (m, 2 H), 7.42 - 7.46 (m, 2 H), 7.33 - 7.37 (m, 3 H), 7.21 (app d, J = 7.8 Hz, 2 H), 5.13 
(dd, J = 8.4, 8.4 Hz, 1 H), 4.30 - 4.44 (m, 4 H), 3.24 (d, J = 8.6 Hz, 2 H), 2.35 (s, 3 H), 1.33 (t, J = 
7.0 Hz, 3 H), 1.32 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 166.6, 165.2, 153.5, 153.2, 
138.6, 133.7, 131.6, 129.7, 129.0, 128.2, 126.2, 125.7, 70.8, 63.8, 63.3, 59.1, 46.8, 21.2, 14.0, 13.9; 
HRMS C24H25N3O6 Calculated = 451.1743, Found = 451.1733 
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Diethyl 1,3-dioxo-2-phenyl-5-(p-tolyl)tetrahydropyrazolo[1,2-a][1,2,4]triazole-6,6(1H)-
dicarboxylate (51d) 
The general cis-diazene cycloaddition procedure was followed using cyclopropane 34d (50 mg, 
0.18 mmol), cis-diazene 49 (63 mg, 0.36 mmol) and GaCl3 (6 mg, 0.036 mmol) to yield the 
compound as a white solid (10 mg, 12%). Rf 0.70 (5:1 Et2O:Pentane); 
1H NMR (400 MHz, CDCl3) 
7.45 - 7.52 (m, 4 H), 7.34 - 7.41 (m, 1 H), 7.23 - 7.25 (m, 2 H), 7.16 - 7.18 (m, 2 H), 5.81 (s, 1 H), 
4.46 (d, J = 13.3 Hz, 1 H), 4.23 - 4.31 (m, 3 H), 3.98 - 4.06 (m, 1 H), 3.80 - 3.88 (m, 1 H), 2.34 (s, 
3 H), 1.25 (t, J = 7.0 Hz, 3 H), 1.10 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 169.4, 164.5, 
156.5, 156.2, 138.9, 132.0, 131.6, 129.3, 129.2, 128.4, 127.3, 125.9, 120.7, 65.7, 65.4, 63.3, 62.2, 
49.8, 21.2, 13.9, 13.6; HRMS C24H25N3O6 Calculated = 451.1743, Found = 451.1733 
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Chapter 4 - Cycloadditions of Donor-Acceptor Cyclobutanes with cis-Diazenes 
 
4.1 Introduction 
 
Cyclobutanes have been utilized for various synthetic uses such as ring expansions,23 
metal-catalyzed activation of the carbon-carbon bonds,24 and Baeyer Villiger oxidations.25 
Because of the unique properties present in cyclobutanes, such as a highly strained ring system, 
they have been modified into Donor-Acceptor (DA) cyclobutanes in a similar way to DA 
cyclopropanes. Because the cyclobutane ring system contains four carbon atoms, a 1,4-dipole 
equivalent (59) may be generated under the appropriate conditions as seen in Scheme 4.1. 
 
 
Scheme 4.1 Reactivity of DA cyclobutanes 
 
The use of DA cyclobutanes has received less attention than DA cyclopropanes, with the 
use of DA cyclobutanes starting around 1986.26 This work later led to the application of DA 
cyclobutanes in cycloaddition chemistry with seminal work done by Saigo in 1991.27 Saigo 
reported that amino-activated cyclobutane mono-ester (60) reacted with aldehydes or ketones 
when treated with TiCl4 to furnish tetrahydropyrans (62) in moderate yields and poor 
diastereoselectivity (Scheme 4.2). 
 
 
Scheme 4.2 Cycloaddition or DA cyclobutane with aldehydes or ketones 
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4.1.1 Alkoxy-Activated Cyclobutane Diesters 
 
The Pagenkopf group began experimenting with alkoxy-activated cyclobutane diesters in 
2010 because of the similarities to DA cyclopropanes, which have been a focus of interest in the 
group.28 Reacting DA cyclobutanes with various dipolarophiles began with first with imines, 
which was followed by aldehydes. Further work included reacting DA cyclobutanes with 
acetylenes and nitrones (Scheme 4.3). 
 
 
Scheme 4.3 Pagenkopf research of DA cyclobutanes 
 
Under Yb(OTf)3 catalysis, DA cyclobutanes undergo a formal [4+2] cycloaddition with 
imines to form piperidines (64) in a stereoselective manner. A similar type of formal [4+2] 
cycloaddition is also possible when aldehydes are used as the dipolarophile, and produce 
tetrahydropyrans (63) again in a stereoselective manner.29 Both of these reactions were discovered 
in 2010 and it was quickly realized that other dipolarophiles would react in a similar way. In 2011, 
the formal [4+3] cycloaddition between DA cyclobutanes and nitrones was discovered. This 
reaction led to oxazepines (65) with stereochemistry that can be controlled based on reaction 
conditions.30 In the same year it was also discovered that terminal alkynes reacted with DA 
cyclobutanes in the presence of BF3·OEt2 as the Lewis acid to generate dihydrooxepines (66).
31 
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4.1.2 Synthesis of DA Cyclobutanes 
 
 To begin exploring the possibility of cycloadditions occurring between DA cyclobutanes 
and cis-diazenes, it was necessary to work with the appropriate starting materials. The Pagenkopf 
group’s success with alkoxy-activated cyclobutane diesters in other cycloaddition reactions 
determined them to be a good choice for the DA cyclobutane. The required alkoxy-activated 
cyclobutane diester was synthesized through a two-step procedure that began with a Knoevenagel 
condensation of diethyl malonate (68) with paraformaldehyde to generate the highly reactive 
methylidene malonate (69). The malonate was then treated with dihydrofuran (70) under Zn(OTf)2 
catalyzed conditions to afford the desired DA cyclobutane (67) as seen in Scheme 4.4. 
 
 
Scheme 4.4 Two-step synthesis of DA cyclobutanes 
 
4.1.3 Cycloadditions of DA Cyclobutanes with cis-Diazenes 
 
 Because the Pagenkopf group was already performing cycloadditions with cis-diazenes for 
DA cyclopropanes, I naturally progressed to trying the same diazene (PTAD) with DA 
cyclobutanes. PTAD was selected as a desirable cis-diazene to work with because of its stability 
and long shelf-life, and it can be easily synthesized using a straightforward synthetic route. A 
common problem with other cis-diazenes is thermal instability leading to decomposition at room 
temperature. Finding alternative cis-diazenes to undergo cycloaddition reactions with DA 
cyclobutanes was made difficult due to their instability at room temperature and the limited 
commercial availability of other cis-diazenes. 
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Scheme 4.5 General cycloaddition of DA cyclobutanes with cis-diazenes 
 The general reaction is shown in scheme 4.5 and the parent molecule generated is a 
hexahydropyridazine (73). Biological assays have shown hexahydropyridazines to exhibit 
moderate levels of anesthetic, antihistaminic, and anticonvulsive activity.32 When PTAD is used 
as the cis-diazene, a 5,6,5-ring system is generated through a formal [4+2] cycloaddition with DA 
cyclobutane (67) as seen in Scheme 4.6. These products may potentially serve as a starting point 
for the synthesis of other useful compounds, and also contain functionality to undergo post-
modification. 
 
Scheme 4.6 Cycloaddition of DA cyclobutanes with PTAD 
 
4.2 Results and Discussion 
 
After some experimentation, it was discovered that cis-diazenes such as PTAD are indeed 
a compatible reaction partner for DA cyclobutanes. The [4+2] cycloaddition was achieved using a 
necessary Lewis acid, and both GaCl3 and Yb(OTf)3 were successful. Optimization of the reaction 
conditions led to GaCl3 being the better choice for a Lewis acid, with the highest yield occurring 
at 5 mol % catalytic loading (Table 4.1). 
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Table 4.1 Cycloaddition of DA cyclobutane with cis-diazene 
 
 
Entrya Cyclobutane 
(Equivalents) 
cis-Diazene 
(Equivalents) 
Lewis 
Acid 
Mol % Yield (%)b 
1 1 1 Yb(OTf)3 10 38 
2 1 1 GaCl3 10 41 
3 1.5 1 GaCl3 10 63 
4 2 1 GaCl3 10 79 
5c 2 1 GaCl3 5 92 
6d 2 1 GaCl3 2 84 
a Typical reaction conditions: To a solution of GaCl3 in 1,2-DCE (3 mL) at room temperature, 
was added cyclobutane (0.44 mmol) and nitrosoarene (0.22 mmol). Reactions were monitored 
by TLC until cyclobutane was consumed. b Isolated yield. c 20 min reaction time. d 90 min 
reaction time. 
 
The cis stereochemistry of product (74c) was deduced from analyzing a crystal structure 
as seen in Figure 4.1. 
 
 
Figure 4.1 Crystal structure of hexahydropyridazine 74c 
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4.2.1 Reaction Scope 
 
 After obtaining optimal reaction conditions for the cycloaddition, the scope was 
investigated to see if other DA cyclobutanes were compatible with PTAD. Good yields were 
obtained using various alkoxy-activated cyclobutane diesters as seen in Figure 4.2. 
 
 
 
Figure 4.2 Cycloadditions of different DA cyclobutanes with PTAD 
  
Reacting DA cyclobutanes with trans-diazenes was attempted but did not result in a 
cycloaddition. This came as no surprise because of the difference in reactivity between trans- 
and cis-diazenes. The difference in reactivity was also observed when working with DA 
cyclopropanes. 
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4.3 Post Modification of Hexahydropyridazine Products 
 
The methodology discovered enables easy access to the hexahydropyridazine ring system 
through an efficient cycloaddition of DA cyclobutanes with cis-diazenes. Using specific DA 
cyclobutanes, the diastereoselectivity can be controlled and can therefore be used in the 
stereoselective synthesis of hexahydropyridazine systems. These systems contain the appropriate 
functionality to undergo different post modification reactions (Scheme 4.7). This demonstrates the 
versatility of the ring system to undergo various transformations to yield different compounds from 
a single product. The post-modified products can then be potentially useful in the synthesis of 
other target molecules or serve in other applications. 
 
 
Scheme 4.7 Potential post modifications of hexahydropyridazine 74b 
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4.4 Experimental 
 The procedures and conditions were the same as described in section 2.3. 
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4.5 Supporting Information 
General Procedure for Cycloaddition of cis-Diazene with DA Cyclobutane 
To a solution of cyclobutane (0.43 mmol, 2.0 equiv) and PTAD (0.22 mmol, 1.0 equiv) in 
1,2-DCE (3 mL) was added GaCl3 (0.01 mmol, 0.05 equiv) and stirred for 30 min at rt. The mixture 
was then concentrated after consumption of cyclobutane (as indicated by TLC) and directly loaded 
onto a packed SiO2 column. Product was purified by flash chromatography (1:1 hexanes/EtOAc) 
to afford the corresponding cycloadducts. 
 
 
Diethyl 8-ethoxy-1,3-dioxo-2-phenyltetrahydro-1H-[1,2,4]triazolo[1,2-a]pyridazine-5,5(6H)-
dicarboxylate (74a) 
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using 
cyclobutane (142 mg, 0.58 mmol), cis-diazene 49 (50 mg, 0.29 mmol) and GaCl3 (2.6 mg, 0.015 
mmol) to yield the compound as a white solid. (109 mg, 90%). Rf 0.20 (3:1 Hexanes:EtOAc); 
 1H 
NMR (600 MHz, CDCl3) 7.50 (app d, J = 8.2 Hz, 2 H), 7.45 (app t, J = 7.9 Hz, 2 H), 7.34 - 7.38 
(m, 1 H), 5.54 (d, J = 1.8 Hz, 1 H), 4.25 - 4.37 (m, 4 H), 3.62 - 3.70 (m, 2 H), 2.69 (ddd, J = 14.1, 
14.1, 4.1 Hz, 1 H), 2.47 - 2.51 (m, 1 H), 2.08 (d, J = 14.1 Hz, 1 H), 1.70 (dddd, J = 14.1, 4.1, 4.1, 
4.1 Hz, 1 H), 1.27 - 1.33 (m, 6 H), 1.23 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 166.2, 
165.8, 153.7, 151.0, 131.0, 129.1, 128.3, 125.7, 77.6, 70.4, 65.0, 63.2, 63.0, 26.5, 25.6, 15.0, 14.1, 
13.8; HRMS C20H25N3O7 Calculated = 419.1693, Found = 419.1699 
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Diethyl 7,9-dioxo-8-phenylhexahydro-2H-furo[2,3-c][1,2,4]triazolo[1,2-a]pyridazine-
5,5(3H)-dicarboxylate (74b) 
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using 
cyclobutane (141 mg, 0.58 mmol), cis-diazene 49 (50 mg, 0.29 mmol) and GaCl3 (2.6 mg, 0.015 
mmol) to yield the compound as a white solid. (111 mg, 92%). Rf 0.50 (1:1 Hexanes:EtOAc); 
 1H 
NMR (400 MHz, CDCl3) 7.45 - 7.53 (m, 4 H), 7.38 (app t, J = 7.0 Hz, 1 H), 5.78 (d, J = 4.3 Hz, 1 
H), 4.29 - 4.37 (m, 4 H), 4.18 - 4.23 (m, 2 H), 4.08 (td,  J = 9.4, 2.0 Hz, 1 H), 2.64 (dd, J = 13.3, 
5.9 Hz, 1 H), 2.40 - 2.48 (m, 1 H), 2.28 - 2.36 (m, 1 H), 2.24 (dd, J = 13.3, 12.1 Hz, 1 H), 1.90 
(ddd, J = 6.6, 6.6, 2.0 Hz, 1 H), 1.34 (t, J = 7.0 Hz, 3 H), 1.32 (t, J = 7.0 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) 166.0, 165.6, 153.3, 150.5, 130.9, 129.2, 129.1, 128.4, 125.8, 80.8, 68.9, 66.2, 63.5, 
63.1, 32.3, 31.7, 30.2, 14.1, 13.8; HRMS C20H23N3O7 Calculated = 417.1536, Found = 417.1530 
 
 
Diethyl 8,10-dioxo-9-phenyloctahydropyrano[2,3-c][1,2,4]triazolo[1,2-a]pyridazine-
6,6(2H)-dicarboxylate (74c) 
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using 
cyclobutane (149 mg, 0.58 mmol), cis-diazene 49 (50 mg, 0.29 mmol) and GaCl3 (2.6 mg, 0.015 
mmol) to yield the compound as a white solid. (97 mg, 78%). Rf 0.48 (1:1 Hexanes:EtOAc); 
 1H 
NMR (400 MHz, CDCl3) 7.42 - 7.50 (m, 4 H), 7.36 (app t, J = 7.0 Hz, 1 H), 5.29 - 5.32 (m, 1 H), 
4.26 - 4.38 (m, 4 H), 4.09 - 4.14 (m, 1 H), 3.65 (td, J = 12.1, 2.3 Hz, 1 H), 2.76 (dd, J = 13.1, 13.1 
Hz, 1 H), 2.37 (dd, J = 13.1, 3.7 Hz, 1 H), 1.90 - 1.95 (m, 2 H), 1.81 - 1.88 (m, 2 H), 1.44 (d, J = 
12.5 Hz, 1 H), 1.24 - 1.34 (m, 6 H); 13C NMR (100 MHz, CDCl3) 166.3, 165.6, 152.6, 150.7, 
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131.0, 129.1, 128.3, 125.8, 78.1, 69.6, 67.9, 63.4, 63.0, 30.0, 29.9, 27.1, 19.6, 14.1, 13.8; HRMS 
C21H25N3O7 Calculated = 431.1693, Found = 431.1693 
 
 
Diethyl 10a-methoxy-1,3-dioxo-2-phenyloctahydro-1H-[1,2,4]triazolo[1,2-a]cinnoline-
5,5(6H)-dicarboxylate (74d) 
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using 
cyclobutane (165 mg, 0.58 mmol), cis-diazene 49 (50 mg, 0.29 mmol) and GaCl3 (2.6 mg, 0.015 
mmol) to yield the compound as a white solid. (99 mg, 75%). Rf 0.21 (3:1 Hexanes:EtOAc); 
 1H 
NMR (400 MHz, CDCl3) 7.41 - 7.47 (m, 4 H), 7.31 - 7.35 (app tt, J = 7.0, 1.8 Hz, 1 H), 4.89 (dd, 
J = 4.1 Hz, 1 H), 4.10 - 4.25 (m, 4 H), 3.85 (dd, J = 6.5, 4.1 Hz, 1 H), 3.45 (s, 3 H), 2.82 (dd, J = 
15.3, 6.5 Hz, 1 H), 2.78 (dd, J = 15.3, 4.1 Hz, 1 H), 2.29 - 2.33 (m, 1 H), 2.10 - 2.19 (m, 2 H), 1.91 
- 1.95 (m, 1 H), 1.66 - 1.70 (m, 2 H), 1.26 (t, J = 7.0 Hz, 3 H), 1.25 (t, J = 7.0 Hz, 3 H); 13C NMR 
(100 MHz, CDCl3) 170.1, 169.2, 153.4, 152.2, 151.7, 129.0, 128.1, 125.7, 100.2, 64.7, 61.8, 61.5, 
54.0, 48.4, 35.9, 31.9, 23.4, 19.0, 14.1; HRMS C23H29N3O7 Calculated = 459.2006, Found = 
460.2090 
 
Diethyl 11a-methoxy-1,3-dioxo-2-phenyldecahydrocyclohepta[c][1,2,4]triazolo[1,2-
a]pyridazine-5,5(1H)-dicarboxylate (74e) 
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using 
cyclobutane (173 mg, 0.58 mmol), cis-diazene 49 (50 mg, 0.29 mmol) and GaCl3 (2.6 mg, 0.015 
mmol) to yield the compound as a white solid. (110 mg, 80%). Rf 0.53 (1:1 Hexanes:EtOAc); 
 1H 
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NMR (400 MHz, CDCl3) 7.48 - 7.50 (m, 2 H), 7.45 (app t, J = 7.9 Hz, 2 H), 7.34 (app t, J = 7.6 
Hz, 1 H), 4.58 (app dd, J = 4.5, 2.3 Hz, 1 H), 4.19 - 4.23 (m, 4 H), 3.47 - 3.53 (m, 1 H), 3.34 (s, 3 
H), 3.27 (s, 3 H), 2.32 - 2.38 (m, 1 H), 2.03 - 2.08 (m, 1 H), 1.91 - 1.95 (m, 2 H), 1.78 - 1.80 (m, 
2 H), 1.53 - 1.65 (m, 5 H), 1.24 - 1.27 (m, 6 H); 13C NMR (100 MHz, CDCl3) 169.6, 169.4, 153.3, 
129.1, 128.1, 125.4, 105.0, 62.3, 61.5, 61.0, 51.3, 50.3, 48.6, 41.0, 30.3, 27.5, 25.2, 24.6, 24.5, 
21.1, 14.1; HRMS C24H31N3O7 Calculated = 473.2162, Found = 473.2165 
 
 
Diethyl 8-(4-methoxyphenyl)-1,3-dioxo-2-phenyltetrahydro-1H-[1,2,4]triazolo[1,2-
a]pyridazine-5,5(6H)-dicarboxylate (74f) 
The general procedure for cycloaddition of cis-diazene with DA cyclobutane was followed using 
cyclobutane (48 mg, 0.16 mmol), cis-diazene 49 (14 mg, 0.08 mmol) and GaCl3 (0.7 mg, 0.004 
mmol) to yield the compound as a white solid. (34 mg, 88%). Rf 0.45 (1:1 Hexanes:EtOAc); 
 1H 
NMR (400 MHz, CDCl3) 7.39 - 7.47 (m, 5 H), 7.34 (app d, J = 8.6 Hz, 2 H), 6.86 (app d, J = 8.6 
Hz, 2 H), 5.11 (dd, J = 11.3, 4.3 Hz, 1 H), 4.20 - 4.31 (m, 4 H), 3.79 (s, 3 H), 3.49 (dd, J = 8.4, 4.5 
Hz, 1 H), 2.09 - 2.23 (m, 2 H), 1.80 - 2.04 (m, 2 H), 1.29 (t, J = 7.0 Hz, 6 H); 13C NMR (100 MHz, 
CDCl3) 169.7, 169.4, 154.1, 129.0, 128.9, 128.1, 125.5, 114.1, 61.9, 59.7, 55.3, 50.7, 29.0, 26.6, 
25.0, 14.1; HRMS C25H27N3O7 Calculated = 481.1849, Found = 481.1837 
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Chapter 5 - Conclusions 
 
 This thesis has investigated the mechanism of reaction between DA cyclopropanes and 
nitrosoarenes.  The reaction of DA cyclopropanes with azo dicarboxylates was also investigated. 
These reactions were studied with the use of cross-over experiments. The information learned from 
these experiments could be used in the development of new reactions. The successful completion 
of these projects demonstrates the usefulness and versatility of DA cyclopropanes in synthetic 
organic chemistry. 
 A breakthrough that was discovered in this thesis included the general pattern of reactivity 
of nitrogen to open a DA cyclopropane, which undergoes fragmentation and generation of a 1,3-
dipole. This reaction type may lead to the discovery of new reactions if further exploration is 
attempted. This reaction represents a novel way of synthesizing heterocyclic compounds and 
incorporating new atoms may allow for construction of new heterocycles. 
 The reaction of DA cyclobutanes with cis-diazenes was also accomplished in a highly 
efficient cycloaddition. The generality of the reaction scope was achieved from the successful 
coupling of different DA cyclobutanes with cis-diazene, PTAD. This project showcased a novel 
approach to the synthesis of hexahydropyridazine systems. These six-membered ring heterocycles 
have limited ways to be created, and can now be efficiently synthetized, which demonstrates the 
usefulness of this chemistry. 
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Cross-Over Experiment #2 
Crude Reaction Mixture 
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Cross-Over Experiment #2 
Isolated Products 
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Appendix 4 - GC-MS Data Chapter 2 
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Cross-Over Experiment #3 Standards 
 
 
 
 
 
 
 
Cross-Over Experiment #3 Reversed (Run #1) 
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Cross-Over Experiment #3 Reversed (Run #1) 
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Cross-Over Experiment #3 Reversed (Run #1) 
Peak #1 
 
Peak #2 
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Cross-Over Experiment #3 Reversed (Run #2) 
 
 
 
 
 
125 
 
 
 
Cross-Over Experiment #3 Reversed (Run #3) 
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